Join the 200th Anniversary Celebration

Original Article

Clinical Spectrum of Obesity and Mutations in the Melanocortin 4 Receptor Gene

I. Sadaf Farooqi, M.D., Ph.D., Julia M. Keogh, B.Sc., Giles S.H. Yeo, Ph.D., Emma J. Lank, B.Sc., Tim Cheetham, M.D., and Stephen O'Rahilly, M.D.

N Engl J Med 2003; 348:1085-1095March 20, 2003

Abstract

Background

Melanocortin 4 receptor (MC4R) deficiency is the commonest monogenic form of obesity. However, the clinical spectrum and mode of inheritance have not been defined, pathophysiological mechanisms leading to obesity are poorly understood, and there is little information regarding genotype–phenotype correlations.

Methods

We determined the nucleotide sequence of the MC4R gene in 500 probands with severe childhood obesity. Family studies were undertaken to examine cosegregation of identified mutations with obesity. Subjects with MC4R deficiency underwent metabolic and endocrine evaluation; the results were correlated with the signaling properties of mutant receptors.

Results

Twenty-nine probands (5.8 percent) had mutations in MC4R; 23 were heterozygous, and 6 were homozygous. Mutation carriers had severe obesity, increased lean mass, increased linear growth, hyperphagia, and severe hyperinsulinemia; homozygotes were more severely affected than heterozygotes. Subjects with mutations retaining residual signaling capacity had a less severe phenotype.

Conclusions

Mutations in MC4R result in a distinct obesity syndrome that is inherited in a codominant manner. Mutations leading to complete loss of function are associated with a more severe phenotype. The correlation between the signaling properties of these mutant receptors and energy intake emphasizes the key role of this receptor in the control of eating behavior in humans.

Media in This Article

Figure 1Mutations in the Melanocortin 4 Receptor (MC4R) Gene (Panel A) and in Vitro Function (Panel B).
Figure 2Pedigrees of 11 Families with a Proband Who Was Heterozygous for a Melanocortin 4 Receptor (MC4R) Mutation (Panel A) and 6 Families with a Homozygous Proband (Panel B).
Article

Although changes in diet and exercise underlie the current global increase in the prevalence of obesity, there is considerable evidence of a substantial genetic contribution to the regulation of body weight.1 Causative mutations underlying several recognizable pleiotropic obesity syndromes (e.g., Bardet–Biedl syndrome) have recently been identified, but in no case has a clear mechanistic link between the product of the mutant gene and disordered energy balance been clarified.2 Study of strains of genetically obese mice has resulted in the discovery of several genes, mutations of which have subsequently been found to lead to severe human obesity. Deficiency of the adipocyte-derived hormone leptin results in obesity, hyperphagia, infertility, and impaired T-cell–mediated immunity in mice3,4 and humans,5,6 and the administration of leptin completely reverses all aspects of the phenotype in both species.7-11 Proopiomelanocortin is regulated by leptin and is cleaved by prohormone convertases to yield α melanocyte-stimulating hormone.12 Loss-of-function mutations in the proopiomelanocortin gene lead to obesity in mice and humans.13,14 The actions of α melanocyte-stimulating hormone on the melanocortin 4 receptor (MC4R) lead to a decrease in food intake,15 and mice with null mutations in MC4R have increased food intake, obesity, and hyperinsulinemia.16

We and others have identified mutations in MC4R in obese subjects.17-19 However, the lack of clinical information has precluded a thorough description of the clinical syndrome or systematic examination of correlations between the genotype and the phenotype. Therefore, we screened 500 subjects with severe, early-onset obesity for mutations in MC4R and conducted clinical studies of those with mutations. We also characterized the in vitro function of mutant receptors and examined relations between molecular and clinical phenotypes.

Methods

Subjects

Subjects with severe obesity of early onset (before 10 years of age) were eligible for entry into the Genetics of Obesity Study (GOOS) and are referred to as probands. We recruited 750 subjects. Standard deviation scores for body-mass index (the weight in kilograms divided by the square of the height in meters) were calculated with the use of reference data from the United Kingdom population.20 Among the probands, the mean (±SD) standard-deviation score for body-mass index was 4.2±0.8. To date, the first consecutive 500 unrelated probands have been examined for mutations in MC4R. Subjects with mutations in MC4R and their relatives were invited to the Wellcome Trust Clinical Research Facility at Addenbrooke's Hospital, Cambridge, United Kingdom.

All studies were approved by the Anglia and Oxford multiregional ethics committee. The clinical studies were performed after approval by the local–regional ethics committee of Cambridge. Each subject, or his or her parent in the case of children younger than 16 years, provided written informed consent (oral consent was obtained from the minors themselves). All clinical studies were conducted in accordance with the principles of the Declaration of Helsinki.

Detection of Mutations and Genotyping

Genomic DNA was isolated from whole-blood lymphocytes, and the coding region of the MC4R gene was amplified by the polymerase chain reaction and sequenced as previously described.17 To determine allelic frequency, we determined the MC4R sequence in 100 alleles from nonobese control subjects from the United Kingdom who were randomly selected from a local population-based cohort.21

Studies of Mutant Receptor Function

Wild-type (normal) and mutant MC4Rs were cloned into the mammalian expression vector pcDNA3 (Invitrogen) as previously reported17 and transiently transfected into HEK293 cells with a luciferase reporter under the control of a promoter that was responsive to cyclic AMP (cAMP),22 according to the manufacturer's protocols (Fugene Reagent, Roche Diagnostics). All transfections incorporated a pRL-CMV plasmid (Promega), which constitutively expresses Renilla luciferase and controls for the efficiency of transfection. Cells were deprived of serum, and various concentrations of α melanocyte-stimulating hormone (Bachem) were added. After the cells were harvested, luciferase activity was determined with a luciferase assay system (Promega). Activation of MC4R increases intracellular cAMP, which stimulates the expression of luciferase. Each experiment was conducted in quadruplicate; values are given as means ±SE. Data were analyzed and curves were fitted with the use of Origin software (OriginLab).

Body Composition, Growth, and Energy Balance

Anthropometry and whole-body dual-energy x-ray absorptiometry to determine body composition were performed as previously described.17 Bone mineral density z scores were calculated with use of the data set of the third National Health and Nutrition Examination Survey.23 The subjects' resting metabolic rate was measured by indirect calorimetry17 after they had slept for eight hours at the clinical research facility. After adjustment for body composition, the resting metabolic rate was compared with that predicted according to age- and sex-specific equations.24,25 Semiquantitative assessment of eating behavior was undertaken in children under 16 years of age. The children were given a 4300-kcal meal at breakfast after an overnight fast, the contents were covertly weighed before the meal and after the children finished eating, and total energy intake and nutrient composition were calculated.10 Energy intake was expressed per kilogram of lean body weight as a simple means of comparing intake among subjects of different ages and body sizes, since no method of adjustment for age or sex has been validated.

Metabolic and Endocrine Studies

Blood samples obtained while the subjects were fasting were analyzed for leptin, lipids, glucose, insulin, thyrotropin, free thyroxine, corticotropin, insulin-like growth factor I, follicle-stimulating hormone, luteinizing hormone, estradiol, and testosterone with the use of standard assays. In addition, 24-hour urine free cortisol was measured in some subjects.

Statistical Analysis

Clinical data are expressed as means ±SD, and in vitro data are expressed as means ±SE. Differences between groups were compared with use of the unpaired Student's t-test. All reported P values are two-sided. P values of less than 0.05 were considered to indicate statistical significance.

Results

Detection of Mutations and Functional Analysis

We identified mutations in 29 of the 500 probands (5.8 percent) that were not found in 100 alleles from randomly selected nonobese subjects (Figure 1AFigure 1Mutations in the Melanocortin 4 Receptor (MC4R) Gene (Panel A) and in Vitro Function (Panel B).). Three variants — V103I, I251L, and T112M — were found in obese and control subjects; these variants have been shown to have no effect on MC4R signaling and were not studied further. Signaling properties of mutant receptors were examined (Figure 1B). Whereas all of the frame-shift mutations and some of the missense mutations resulted in complete loss of signaling, some of the missense mutations encoded receptors with residual ability to generate cAMP in response to ligand (Figure 1B and Table 1Table 1Mutations in the Melanocortin 4 Receptor (MC4R) Gene Associated with Severe Obesity in Childhood and Loss of Function in Vitro.).

Mode of Inheritance

All relatives of the probands were genotyped at MC4R by direct nucleotide sequencing. MC4R mutations identified in heterozygous probands segregated with early-onset obesity with 100 percent penetrance (Figure 2AFigure 2Pedigrees of 11 Families with a Proband Who Was Heterozygous for a Melanocortin 4 Receptor (MC4R) Mutation (Panel A) and 6 Families with a Homozygous Proband (Panel B).). In six families the proband was homozygous for a mutation in MC4R (Figure 2B), including one (Family 12) in which the proband appeared to be homozygous for a deletion of MC4R. In these families all 12 homozygotes became severely obese at an early age; in contrast, the prevalence of early-onset obesity was only 68 percent among heterozygous subjects (17 of 25). Heterozygotes from these families were less obese than their homozygous relatives, as indicated by mean (±SD) body-mass index standard-deviation scores of 1.92±1.6 and 4.64±1.2, respectively (P=0.001). These findings indicate that the obesity resulting from mutations in MC4R is associated with a codominant mode of inheritance.

Clinical Phenotype of MC4R Deficiency

Clinical Presentation, Body Composition, and Growth

The clinical phenotype of MC4R deficiency was studied in 12 probands and 39 of their relatives with early-onset obesity who had mutations in MC4R. This group consisted of 42 heterozygotes and 9 homozygotes. The mean body-mass index standard-deviation score for the 51 subjects was 3.14±1.61, with a mean score of 2.79±1.38 among heterozygotes and 4.81±1.63 among homozygotes. Body weight deviated from predicted United Kingdom reference percentiles in the first year of life in over 80 percent of those for whom early growth charts were available (Figure 3AFigure 3Growth (Panels A and B) and Body Composition (Panel C) in Subjects with Melanocortin 4 Receptor (MC4R) Deficiency.). At all ages, but particularly during the first five years, the standard-deviation scores for height of children with MC4R deficiency were greater than those of obese children without MC4R mutations (Figure 3B). Serum concentrations of insulin-like growth factor I were appropriate for age in all instances (data not shown).

Dual-energy x-ray absorptiometry was used to examine body composition in 48 subjects. Although the mean percentage of body fat among carriers of MC4R mutations was clearly abnormal at 42.9±8.6 percent (normal range, 15 to 25), the relative contribution of fat-free mass to overall weight was greater in these subjects than in subjects with leptin deficiency who had a similar body-mass index (mean fat mass, 57.0 percent).11 Thus, MC4R deficiency is characterized by an increase in both fat and lean mass. Homozygotes had a higher mean percentage of body fat than heterozygotes (49.5±4.7 percent vs. 41.6±6.6 percent, P=0.01). The characteristic appearance of a child with MC4R deficiency — severely obese and tall, with increased fat-free mass as well as fat mass — is illustrated in Figure 3C.

We have previously reported that subjects with MC4R deficiency have increased bone mineral density and bone mineral content.17 These extended clinical studies confirmed those observations: 37 of 44 subjects with MC4R deficiency (84 percent) had a bone mineral density z score of more than 1 (mean, 1.7±0.9).

Energy Balance

All subjects had a history of increased appetite, particularly in childhood. The energy consumed by carriers of MC4R mutations at an ad libitum meal was three times that of their unaffected siblings, after adjustment for lean body mass (mean, 36.4±8.4 kcal per kilogram of lean mass vs. 11±1.9 kcal per kilogram of lean mass; P=0.001). In general, older children (those 11 to 15 years of age) were less hyperphagic and ate less at the test meal (Figure 4AFigure 4Effects of Age and in Vitro Function of the Mutant Melanocortin 4 Receptor (MC4R) on Mean (±SD) ad Libitum Energy Intake (Panels A and C) and Plasma Insulin Concentrations (Panel B).). The resting metabolic rate of subjects with MC4R mutations was similar to that predicted on the basis of age- and sex-specific equations after correction for lean body mass (r2=0.84 for adults, r2=0.94 for boys, and r2=0.70 for girls) (see Supplementary Appendix 1 and 2, available with the full text of this article at http://www.nejm.org).

Metabolic and Endocrine Function

All subjects with MC4R deficiency were euglycemic, but plasma insulin concentrations were significantly elevated as compared with those in obese subjects matched for age, standard-deviation score for body-mass index, and sex who did not have MC4R mutations (Figure 4B). There was also an age-dependent effect: children had higher plasma insulin concentrations than adults with MC4R deficiency (data not shown).

Serum lipid concentrations and urinary 24-hour free cortisol excretion were within normal ranges, and serum leptin concentrations were appropriate for fat mass (data not shown). All subjects had free thyroxine concentrations in the normal range. Four subjects had a slight elevation in thyrotropin, and one a subnormal concentration of thyrotropin (see Supplementary Appendix 3, available with the full text of this article at http://www.nejm.org). Gonadotropin secretion, concentrations of sex steroids, and secondary sexual characteristics were appropriate for age in affected children (data not shown). None of the adults reported a history of infertility, males did not report decreased erectile function or decreased libido, and all females of reproductive age had regular menstrual cycles.

Relation between Genotype and Clinical Phenotype

To examine whether functional properties of particular mutant MC4Rs might influence the clinical phenotype, standard-deviation scores for body-mass index and height, energy intake at the test meal, and fasting plasma insulin concentrations were compared in subjects with complete loss of function of MC4R and those with a partial loss of function. Since the phenotype appears to change with age, only children (those younger than 16 years) were compared. The 23 subjects who were heterozygous for nonfunctional mutant receptors were more obese than the 22 with partially functioning mutant receptors (body-mass index standard-deviation score, 3.3±1.1 vs. 1.9±1.3; P=0.005). For each phenotype, subjects with a mutation resulting in complete loss of function in vitro were more severely affected (Table 2Table 2Correlations between Genotype and Phenotype in Children with Melanocortin 4 Receptor (MC4R) Deficiency.). For variables that did not appear to be affected by MC4R deficiency, such as resting metabolic rate per kilogram of lean mass, there was no correlation between genotype and phenotype. Figure 4C shows the results of the test meal in heterozygotes with partially functioning receptors and those with inactive receptors; for comparison, results are also shown for two children with congenital leptin deficiency before and after leptin therapy.

Discussion

In this large study, we found that 5.8 percent of subjects with severe obesity commencing in childhood had pathogenic mutations in MC4R. Thus, MC4R deficiency represents the commonest known monogenic obesity disorder. The lower prevalence reported in some studies may be explained by the differences in prevalence in certain ethnic groups,26 but it may also reflect the later onset and reduced severity of obesity of subjects in these studies.27 The great majority of subjects thus far described have been heterozygotes, with only one homozygote17 and one compound heterozygote18 reported. We identified five additional homozygous probands, allowing us to examine the mode of inheritance in a more detailed manner. We found complete penetrance of early-onset obesity in heterozygous probands and found that homozygous probands were more obese than heterozygotes in these families. Thus, codominance is the most appropriate descriptor for the mode of inheritance, a finding supported by the pattern of inheritance of obesity seen in heterozygous and homozygous Mc4r knockout mice.

However, although all homozygotes in the families of homozygous probands were severely obese, only 68 percent of heterozygotes were obese, differences that cannot be explained by the in vitro function of these mutations. Since all homozygous probands were of Indo–European origin, the penetrance of MC4R mutations may vary in different ethnic groups. Given the large number of potential influences on body weight, it is not surprising that genetic and environmental modifiers will have major effects in some pedigrees. Such effects may also explain differences in the severity of the clinical phenotype observed in other populations.

MC4R deficiency is characterized by an increase in lean body mass and bone mineral density, increased linear growth, hyperphagia, and severe hyperinsulinemia. Most of these features are seen in Mc4r knockout mice, suggesting the preservation of the relevant melanocortin pathways between rodents and humans. We confirmed that ad libitum energy intake was greatly increased in children with MC4R deficiency as compared with their unaffected siblings. This finding was consistent with their reported food-seeking behavior in the free-living situation. However, all subjects with MC4R deficiency, including those who were homozygous for a deletion of MC4R, had a lower ad libitum food intake than those with leptin deficiency (Figure 4C), suggesting that some of the inhibitory effects of leptin on food intake may be mediated by other neuropeptides.

We found no evidence of a major deficit in basal energy expenditure in subjects with MC4R deficiency, although Mc4r knockout mice have a 10 percent reduction in basal oxygen consumption.28 This may reflect a true species difference or subtle defects in human energy expenditure, which may be detectable only when energy homeostasis is perturbed. In Mc4r knockout mice, overfeeding with a high-fat diet leads to increased feed efficiency and is associated with a failure to increase diet-induced thermogenesis, suggesting that MC4R has a key role in adaptive thermogenesis.29

All obese subjects with MC4R deficiency had severe hyperinsulinemia. Severe hyperinsulinemia, which appears before the onset of hyperphagia or obesity in Mc4r knockout mice, can be blocked by the administration of an α-adrenergic blocker, suggesting a role for the central melanocortin pathways in activating sympathetic drive to the pancreas.30,31 Whether MC4R directly regulates insulin secretion in humans is yet to be determined. The severe, early hyperinsulinemia may contribute to the increased linear growth associated with MC4R deficiency, since no evidence of excessive secretion of growth hormone has been found in either rodents or humans.

The development of puberty and fertility were normal in subjects with MC4R deficiency, in contrast to findings in obese subjects with mutations in leptin, leptin receptor, or PC-1,6,32,33 suggesting that the effects of leptin on reproductive function are not mediated by MC4R. Male subjects with MC4R deficiency did not report decreased erectile function, whereas pharmacologic MC4R activation in mice has been reported to increase erections and sexual behavior.34 We found no clear evidence of an effect on the thyroid axis, which is consistent with the normal thyroid function of Mc4r knockout mice.16

There was an age-related decrease in hyperinsulinemia, which parallels the apparent amelioration of hyperphagia that seems to occur with adulthood in these subjects. As yet there is no explanation for our observation that the phenotype becomes less prominent with age.

Finally, we found evidence of a correlation between the in vitro function of mutant MC4Rs and the severity of the clinical phenotype. All aspects of the phenotype were more severe in those with complete loss as opposed to partial loss of function of MC4R, and this finding appeared to be consistent for both heterozygotes and homozygotes. Our findings suggest that the regulation of body weight in humans is sensitive to variations in the amount of functional MC4R. The correlation between the in vitro properties of a neuropeptide receptor and a measure of a complex human behavior such as food intake is striking and perhaps unique. Our data provide compelling confirmation of the critical role of MC4R in the control of eating behavior and fat mass in humans.

Supported by grants from the Wellcome Trust (to Drs. Farooqi and O'Rahilly) and the Medical Research Council (to Dr. O'Rahilly) and by an unconditional grant from Merck Pharmaceuticals to support patient studies.

We are indebted to the patients and their families for their participation.

Source Information

From the Genetics of Obesity Collaborative Group (T.C.) and the University Departments of Medicine and Clinical Biochemistry (I.S.F., J.M.K., G.H.S.Y., E.J.L., S.O.'R.), Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge, United Kingdom.

Address reprint requests to Dr. O'Rahilly at the Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge CB2 2QQ, United Kingdom, or at .

Appendix

Other members of the Genetics of Obesity Collaborative Group are as follows: Drs. R. Stanhope, B. Houlsby, D. Matthews, P. Clayton, E. Crowne, R. Cooke, N. Lingham, B. Adler, M. Rossitor, S. Shakil, S. Sawhney, B. Nauriah, and G. Butler.

References

References

  1. 1

    Barsh GS, Farooqi IS, O'Rahilly S. Genetics of body-weight regulation. Nature 2000;404:644-651
    Web of Science | Medline

  2. 2

    Katsanis N, Lupski JR, Beales PL. Exploring the molecular basis of Bardet-Biedl syndrome. Hum Mol Genet 2001;10:2293-2299
    CrossRef | Web of Science | Medline

  3. 3

    Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432[Erratum, Nature 1995;374:479.]
    CrossRef | Web of Science | Medline

  4. 4

    Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998;394:897-901
    CrossRef | Web of Science | Medline

  5. 5

    Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997;387:903-908
    CrossRef | Web of Science | Medline

  6. 6

    Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 1998;18:213-5
    CrossRef | Web of Science | Medline

  7. 7

    Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995;269:546-549
    CrossRef | Web of Science | Medline

  8. 8

    Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995;269:543-546
    CrossRef | Web of Science | Medline

  9. 9

    Pelleymounter MA, Cullen MJ, Baker MB, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995;269:540-543
    CrossRef | Web of Science | Medline

  10. 10

    Farooqi IS, Jebb SA, Langmack G, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999;341:879-884
    Full Text | Web of Science | Medline

  11. 11

    Farooqi IS, Matarese G, Lord GM, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 2002;110:1093-103
    CrossRef | Web of Science | Medline

  12. 12

    Cheung CC, Clifton DK, Steiner RA. Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 1997;138:4489-4492
    CrossRef | Web of Science | Medline

  13. 13

    Yaswen L, Diehl N, Brennan MB, Hochgeschwender U. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med 1999;5:1066-1070
    CrossRef | Web of Science | Medline

  14. 14

    Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 1998;19:155-157
    CrossRef | Web of Science | Medline

  15. 15

    Yeo GS, Farooqi IS, Challis BG, Jackson RS, O'Rahilly S. The role of melanocortin signalling in the control of body weight: evidence from human and murine genetic models. QJM 2000;93:7-14
    CrossRef | Medline

  16. 16

    Huszar D, Lynch CA, Fairchild-Huntress V, et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997;88:131-141
    CrossRef | Web of Science | Medline

  17. 17

    Farooqi IS, Yeo GS, Keogh JM, et al. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 2000;106:271-279
    CrossRef | Web of Science | Medline

  18. 18

    Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, Froguel P. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 2000;106:253-262
    CrossRef | Web of Science | Medline

  19. 19

    Hinney A, Schmidt A, Nottebom K, et al. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J Clin Endocrinol Metab 1999;84:1483-1486
    CrossRef | Web of Science | Medline

  20. 20

    Cole TJ, Freeman JV, Preece MA. Body mass index reference curves for the UK, 1990. Arch Dis Child 1995;73:25-29
    CrossRef | Web of Science | Medline

  21. 21

    Williams DR, Wareham NJ, Brown DC, et al. Undiagnosed glucose intolerance in the community: the Isle of Ely Diabetes Project. Diabet Med 1995;12:30-35
    CrossRef | Web of Science | Medline

  22. 22

    Persani L, Tonacchera M, Beck-Peccoz P, et al. Measurement of cAMP accumulation in Chinese hamster ovary cells transfected with the recombinant human TSH receptor (CHO-R): a new bioassay for human thyrotropin. J Endocrinol Invest 1993;16:511-519
    Web of Science | Medline

  23. 23

    Wahner HW, Looker A, Dunn WL, Walters LC, Hauser MF, Novak C. Quality control of bone densitometry in a national health survey (NHANES III) using three mobile examination centers. J Bone Miner Res 1994;9:951-960
    CrossRef | Web of Science | Medline

  24. 24

    Cunningham JJ. Body composition as a determinant of energy expenditure: a synthetic review and a proposed general prediction equation. Am J Clin Nutr 1991;54:963-969
    Web of Science | Medline

  25. 25

    DeLany JP, Bray GA, Harsha DW, Volaufova J. Energy expenditure in preadolescent African American and white boys and girls: the Baton Rouge Children's Study. Am J Clin Nutr 2002;75:705-713
    Web of Science | Medline

  26. 26

    Ohshiro Y, Sanke T, Ueda K, et al. Molecular scanning for mutations in the melanocortin-4 receptor gene in obese/diabetic Japanese. Ann Hum Genet 1999;63:483-487
    CrossRef | Web of Science | Medline

  27. 27

    Jacobson P, Ukkola O, Rankinen T, et al. Melanocortin 4 receptor sequence variations are seldom a cause of human obesity: the Swedish Obese Subjects, the HERITAGE Family Study, and a Memphis cohort. J Clin Endocrinol Metab 2002;87:4442-4446
    CrossRef | Web of Science | Medline

  28. 28

    Ste Marie L, Miura GI, Marsh DJ, Yagaloff K, Palmiter RD. A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors. Proc Natl Acad Sci U S A 2000;97:12339-12344
    CrossRef | Web of Science | Medline

  29. 29

    Butler AA, Marks DL, Fan W, Kuhn CM, Bartolome M, Cone RD. Melanocortin-4 receptor is required for acute homeostatic responses to increased dietary fat. Nat Neurosci 2001;4:605-611
    CrossRef | Web of Science | Medline

  30. 30

    Fan W, Dinulescu DM, Butler AA, Zhou J, Marks DL, Cone RD. The central melanocortin system can directly regulate serum insulin levels. Endocrinology 2000;141:3072-3079
    CrossRef | Web of Science | Medline

  31. 31

    Obici S, Feng Z, Tan J, Liu L, Karkanias G, Rossetti L. Central melanocortin receptors regulate insulin action. J Clin Invest 2001;108:1079-1085
    Web of Science | Medline

  32. 32

    Clement K, Vaisse C, Lahlou N, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998;392:398-401
    CrossRef | Web of Science | Medline

  33. 33

    Jackson RS, Creemers JW, Ohagi S, et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet 1997;16:303-306
    CrossRef | Web of Science | Medline

  34. 34

    Van der Ploeg LH, Martin WJ, Howard AD, et al. A role for the melanocortin 4 receptor in sexual function. Proc Natl Acad Sci U S A 2002;99:11381-11386
    CrossRef | Web of Science | Medline

Citing Articles (322)

Citing Articles

  1. 1

    Jong-Woo Sohn, Kevin W. Williams. (2012) Functional Heterogeneity of Arcuate Nucleus Pro-Opiomelanocortin Neurons: Implications for Diverging Melanocortin Pathways. Molecular Neurobiology
    CrossRef

  2. 2

    Huxing Cui, Brittany L. Mason, Charlotte Lee, Akinori Nishi, Joel K. Elmquist, Michael Lutter. (2012) Melanocortin 4 receptor signaling in dopamine 1 receptor neurons is required for procedural memory learning. Physiology & Behavior
    CrossRef

  3. 3

    M S Faith, A Pietrobelli, M Heo, S L Johnson, K L Keller, S B Heymsfield, D B Allison. (2012) A twin study of self-regulatory eating in early childhood: estimates of genetic and environmental influence, and measurement considerations. International Journal of Obesity
    CrossRef

  4. 4

    Wendy K. Chung. (2012) An overview of mongenic and syndromic obesities in humans. Pediatric Blood & Cancer 58:1, 122-128
    CrossRef

  5. 5

    Chao Zhang, Paul M. Forlano, Roger D. Cone. (2012) AgRP and POMC Neurons Are Hypophysiotropic and Coordinately Regulate Multiple Endocrine Axes in a Larval Teleost. Cell Metabolism
    CrossRef

  6. 6

    Po-Hsiu Kuo, Chung-Feng Kao, Po-Yu Chen, Chun-Hsin Chen, Yau-Sheng Tsai, Mong-Lian Lu, Ming-Chyi Huang. (2011) Polymorphisms of INSIG2, MC4R, and LEP Are Associated With Obesity- and Metabolic-Related Traits in Schizophrenic Patients. Journal of Clinical Psychopharmacology 31:6, 705-711
    CrossRef

  7. 7

    Elaine Preston, Gregory J. Cooney, Donna Wilks, Katherine Baran, Lei Zhang, Edward W. Kraegen, Amanda Sainsbury. (2011) Central neuropeptide Y infusion and melanocortin 4 receptor antagonism inhibit thyrotropic function by divergent pathways. Neuropeptides 45:6, 407-415
    CrossRef

  8. 8

    Xiaoqun Qin, Xiangping Qu, David Coy, H. Christian Weber. (2011) A Selective Human Bombesin Receptor Subtype-3 Peptide Agonist Mediates CREB Phosphorylation and Transactivation. Journal of Molecular Neuroscience
    CrossRef

  9. 9

    J Wang, H Mei, W Chen, Y Jiang, W Sun, F Li, Q Fu, F Jiang. (2011) Study of eight GWAS-identified common variants for association with obesity-related indices in Chinese children at puberty. International Journal of Obesity
    CrossRef

  10. 10

    Melissa K. Crocker, Jack A. Yanovski. (2011) Pediatric Obesity: Etiology and Treatment. Pediatric Clinics of North America 58:5, 1217-1240
    CrossRef

  11. 11

    Kazuma Ogiso, Akihiro Asakawa, Haruka Amitani, Akio Inui. (2011) Ghrelin and anorexia nervosa: A psychosomatic perspective. Nutrition 27:10, 988-993
    CrossRef

  12. 12

    Sarah Hart-Unger, Kenneth S. Korach. (2011) Estrogens and Obesity: Is It All in Our Heads?. Cell Metabolism 14:4, 435-436
    CrossRef

  13. 13

    R van Boxtel, B Vroling, P Toonen, I J Nijman, H van Roekel, M Verheul, C Baakman, V Guryev, G Vriend, E Cuppen. (2011) Systematic generation of in vivo G protein-coupled receptor mutants in the rat. The Pharmacogenomics Journal 11:5, 326-336
    CrossRef

  14. 14

    Julie Bienertová-Vašků, Petr Bienert, Dalibor Valík, Anna Vašků. (2011) Melanocortin system in cancer-related cachexia. Central European Journal of Medicine 6:5, 550-557
    CrossRef

  15. 15

    Fei Wang, De Run Tian, Patrick Tso, Ji Sheng Han. (2011) Arcuate nucleus of hypothalamus is involved in mediating the satiety effect of electroacupuncture in obese rats. Peptides
    CrossRef

  16. 16

    T A P Lett, T J M Wallace, N I Chowdhury, A K Tiwari, J L Kennedy, D J Müller. (2011) Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications. Molecular Psychiatry
    CrossRef

  17. 17

    Xiaoye Shan, Giles S. H. Yeo. (2011) Central leptin and ghrelin signalling: Comparing and contrasting their mechanisms of action in the brain. Reviews in Endocrine and Metabolic Disorders 12:3, 197-209
    CrossRef

  18. 18

    Zhi-Qiang Wang, Ya-Xiong Tao. (2011) Functional studies on twenty novel naturally occurring melanocortin-4 receptor mutations. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1812:9, 1190-1199
    CrossRef

  19. 19

    Katharine F. Hunt, Yee Seun Cheah, Stephanie A. Amiel. 2011. Brain Insulin Resistance. , 139-164.
    CrossRef

  20. 20

    Yves Rolland, Graziano Onder, John E. Morley, Sophie Gillette-Guyonet, Gabor Abellan van Kan, Bruno Vellas. (2011) Current and Future Pharmacologic Treatment of Sarcopenia. Clinics in Geriatric Medicine 27:3, 423-447
    CrossRef

  21. 21

    J M Hester, M R Wing, J Li, N D Palmer, J Xu, P J Hicks, B H Roh, J M Norris, L E Wagenknecht, C D Langefeld, B I Freedman, D W Bowden, M C Y Ng. (2011) Implication of European-derived adiposity loci in African Americans. International Journal of Obesity
    CrossRef

  22. 22

    Harald Brumm, Jessica Mühlhaus, Florian Bolze, Susann Scherag, Anke Hinney, Johannes Hebebrand, Susanna Wiegand, Martin Klingenspor, Annette Grüters, Heiko Krude, Heike Biebermann. (2011) Rescue of Melanocortin 4 Receptor (MC4R) Nonsense Mutations by Aminoglycoside-Mediated Read-Through. Obesity
    CrossRef

  23. 23

    Leonidas H. Duntas, Jacques Orgiazzi, Georg Brabant. (2011) The interface between thyroid and diabetes mellitus. Clinical Endocrinology 75:1, 1-9
    CrossRef

  24. 24

    G.A. Martos-Moreno, J. Argente. (2011) Obesidades pediátricas: de la lactancia a la adolescencia. Anales de Pediatría 75:1, 63.e1-63.e23
    CrossRef

  25. 25

    Cathrine Laustrup Møller, Kirsten Raun, Marianne Lambert Jacobsen, Thomas Åskov Pedersen, Birgitte Holst, Kilian W. Conde-Frieboes, Birgitte Schjellerup Wulff. (2011) Characterization of murine melanocortin receptors mediating adipocyte lipolysis and examination of signalling pathways involved. Molecular and Cellular Endocrinology 341:1-2, 9-17
    CrossRef

  26. 26

    Sarah Keildson, Cecilia M Lindgren. (2011) Obesity: is Type II diabetes a foregone conclusion or further dependent on genetic susceptibility?. Diabetes Management 1:4, 413-422
    CrossRef

  27. 27

    Rahul Pandit, Johannes W. de Jong, Louk J.M.J. Vanderschuren, Roger A.H. Adan. (2011) Neurobiology of overeating and obesity: The role of melanocortins and beyond. European Journal of Pharmacology 660:1, 28-42
    CrossRef

  28. 28

    Marijke W.A. de Backer, Susanne E. la Fleur, Roger A.H. Adan. (2011) Both overexpression of agouti-related peptide or neuropeptide Y in the paraventricular nucleus or lateral hypothalamus induce obesity in a neuropeptide- and nucleus specific manner. European Journal of Pharmacology 660:1, 148-155
    CrossRef

  29. 29

    Oliver J. Marston, Alastair S. Garfield, Lora K. Heisler. (2011) Role of central serotonin and melanocortin systems in the control of energy balance. European Journal of Pharmacology 660:1, 70-79
    CrossRef

  30. 30

    Shwetha Ramachandrappa, I. Sadaf Farooqi. (2011) Genetic approaches to understanding human obesity. Journal of Clinical Investigation 121:6, 2080-2086
    CrossRef

  31. 31

    Ruth J.F. Loos. (2011) The genetic epidemiology of melanocortin 4 receptor variants. European Journal of Pharmacology 660:1, 156-164
    CrossRef

  32. 32

    Min Chen, Nicholas M. Nemechek, Eralda Mema, Jie Wang, Lee S. Weinstein. (2011) Effects of deficiency of the G protein Gsα on energy and glucose homeostasis. European Journal of Pharmacology 660:1, 119-124
    CrossRef

  33. 33

    Jacqueline E. Siljee-Wong. (2011) Melanocortin MC4 receptor expression sites and local function. European Journal of Pharmacology 660:1, 234-240
    CrossRef

  34. 34

    Kevin W. Williams, Michael M. Scott, Joel K. Elmquist. (2011) Modulation of the central melanocortin system by leptin, insulin, and serotonin: Co-ordinated actions in a dispersed neuronal network. European Journal of Pharmacology 660:1, 2-12
    CrossRef

  35. 35

    Jin Yan, Ya-Xiong Tao. (2011) Pharmacologic of canine melancortin-4 receptor and its natural variant V213F. Domestic Animal Endocrinology
    CrossRef

  36. 36

    M W A de Backer, S E la Fleur, M A D Brans, A J van Rozen, M C M Luijendijk, M Merkestein, K M Garner, E M van der Zwaal, R A H Adan. (2011) Melanocortin receptor-mediated effects on obesity are distributed over specific hypothalamic regions. International Journal of Obesity 35:5, 629-641
    CrossRef

  37. 37

    Blanca M. Herrera, Sarah Keildson, Cecilia M. Lindgren. (2011) Genetics and epigenetics of obesity. Maturitas 69:1, 41-49
    CrossRef

  38. 38

    Joram D. Mul, Ruben van Boxtel, Dylan J.M. Bergen, Maike A.D. Brans, Jan H. Brakkee, Pim W. Toonen, Keith M. Garner, Roger A.H. Adan, Edwin Cuppen. (2011) Melanocortin Receptor 4 Deficiency Affects Body Weight Regulation, Grooming Behavior, and Substrate Preference in the Rat. Obesity
    CrossRef

  39. 39

    I. K. Lyadskiy, A. A. Getya, K. F. Pochernyaev. (2011) Association of the Asp298Asn polymorphism in the mc4r gene with back fat thickness in pigs of the large white breed. Cytology and Genetics 45:2, 106-109
    CrossRef

  40. 40

    I. Sadaf Farooqi. (2011) Genetic, molecular and physiological insights into human obesity. European Journal of Clinical Investigation 41:4, 451-455
    CrossRef

  41. 41

    2011. References. , 283-360.
    CrossRef

  42. 42

    Yi-Chun Loraine Tung, Giles S. H. Yeo. (2011) From GWAS to biology: lessons from FTO. Annals of the New York Academy of Sciences 1220:1, 162-171
    CrossRef

  43. 43

    Linda van den Berg, Olivier van Beekum, Peter Heutink, Bram A. Felius, Monique P.M. van de Heijning, Stefan Strijbis, Rosalina van Spaendonk, Daniela Piancatelli, Keith M. Garner, Rajae El Aouad, Erik Sistermans, Roger A.H. Adan, Henriette A. Delemarre-van de Waal. (2011) Melanocortin-4 Receptor Gene Mutations in a Dutch Cohort of Obese Children. Obesity 19:3, 604-611
    CrossRef

  44. 44

    Kilian Conde-Frieboes, Michael Ankersen, Jens Breinholt, Birgit Sehested Hansen, Kirsten Raun, Henning Thøgersen, Birgitte S. Wulff. (2011) Serendipitous discovery of a new class of agonists for the melanocortin 1 and 4 receptors and a new class of cyclophanes. Bioorganic & Medicinal Chemistry Letters 21:5, 1459-1463
    CrossRef

  45. 45

    I R Aslan, S A Ranadive, B A Ersoy, S J Rogers, R H Lustig, C Vaisse. (2011) Bariatric surgery in a patient with complete MC4R deficiency. International Journal of Obesity 35:3, 457-461
    CrossRef

  46. 46

    Chung-Il Cho, Deuk-Hwan Lee. (2011) Study on Genetic Evaluation using Genomic Information in Animal Breeding - Simulation Study for Estimation of Marker Effects. Journal of Animal Science and Technology 53:1, 1-6
    CrossRef

  47. 47

    Hong-Chul Jang, Sang-Wook Kim, Da-Jeong Lim, Jae-Young Kim, Kyu-Ho Cho, Myung-Jick Kim, Ji-Woong Lee, Bong-Hwan Choi, Tae-Hun Kim. (2011) Association of Single Nucleotide Polymorphism (SNP) in the PGK 2 Gene with Growth Traits in Pigs. Journal of Animal Science and Technology 53:1, 15-22
    CrossRef

  48. 48

    Matthew A. Sabin, George A. Werther, Wieland Kiess. (2011) Genetics of obesity and overgrowth syndromes. Best Practice & Research Clinical Endocrinology & Metabolism 25:1, 207-220
    CrossRef

  49. 49

    J. R. Greenfield. (2011) Melanocortin Signalling and the Regulation of Blood Pressure in Human Obesity. Journal of Neuroendocrinology 23:2, 186-193
    CrossRef

  50. 50

    Jari Rossi, Nina Balthasar, David Olson, Michael Scott, Eric Berglund, Charlotte E. Lee, Michelle J. Choi, Danielle Lauzon, Bradford B. Lowell, Joel K. Elmquist. (2011) Melanocortin-4 Receptors Expressed by Cholinergic Neurons Regulate Energy Balance and Glucose Homeostasis. Cell Metabolism 13:2, 195-204
    CrossRef

  51. 51

    Sara L. Hargrave, Kimberly P. Kinzig. (2011) Repeated gastric distension alters food intake and neuroendocrine profiles in rats. Physiology & Behavior 105:4, 975-981
    CrossRef

  52. 52

    M. Mencarelli, B. Dubern, R. Alili, S. Maestrini, L. Benajiba, M. Tagliaferri, P. Galan, M. Rinaldi, C. Simon, P. Tounian, S. Hercberg, A. Liuzzi, A. M. Di Blasio, K. Clement. (2011) Rare melanocortin-3 receptor mutations with in vitro functional consequences are associated with human obesity. Human Molecular Genetics 20:2, 392-399
    CrossRef

  53. 53

    Irena Aldhoon Hainerová, Hana Zamrazilová, Dana Sedláčková, Vojtěch Hainer. (2011) Hypogonadotropic Hypogonadism in a Homozygous <i>MC4R</i> Mutation Carrier and the Effect of Sibutramine Treatment on Body Weight and Obesity-Related Health Risks. Obesity Facts 4:4, 3-3
    CrossRef

  54. 54

    Eleanor R Grimm, Nanette I Steinle. (2011) Genetics of eating behavior: established and emerging concepts. Nutrition Reviews 69:1, 52-60
    CrossRef

  55. 55

    S. Buchbinder, U. Bärtsch, M. Müller, M. Zorn, P.P. Nawroth, T. Schilling. (2011) A novel missense mutation T101N in the melanocortin-4 receptor gene associated with obesity. Genetics and Molecular Research 10:2, 1042-1049
    CrossRef

  56. 56

    Joseph Skelton, Gail Cohen. 2011. Obesity. , 154-165.
    CrossRef

  57. 57

    Patrick Tounian. (2011) Programming towards Childhood Obesity. Annals of Nutrition and Metabolism 58:s2, 30-41
    CrossRef

  58. 58

    Jeffrey M. Friedman. (2011) Leptin and the Regulation of Body Weigh. The Keio Journal of Medicine 60:1, 1-9
    CrossRef

  59. 59

    Doreen Zegers, Sigri Beckers, Fenna de Freitas, Armand V. Peeters, Ilse L. Mertens, Stijn L. Verhulst, Raoul P. Rooman, Jean-Pierre Timmermans, Kristine N. Desager, Guy Massa, Luc F. Van Gaal, Wim Van Hul. (2011) Identification of Three Novel Genetic Variants in the Melanocortin-3 Receptor of Obese Children. Obesity 19:1, 152-159
    CrossRef

  60. 60

    Claire L. Donohoe, Aoife M. Ryan, John V. Reynolds. (2011) Cancer Cachexia: Mechanisms and Clinical Implications. Gastroenterology Research and Practice 2011, 1-13
    CrossRef

  61. 61

    Andrea R V R Horimoto, Suely R Giolo, Camila M Oliveira, Rafael O Alvim, Julia P Soler, Mariza de Andrade, Jose E Krieger, Alexandre C Pereira. (2011) Heritability of physical activity traits in Brazilian families: the Baependi Heart Study. BMC Medical Genetics 12:1, 155
    CrossRef

  62. 62

    Ga-Ae Gang, Sung-Sub Choi, Tae-Joon Park, Yong-Ae Kim. (2010) Optimization of the experimental conditions for structural studies of the second transmembrane domain from human wild-type & mutant melanocortin-4 receptor. Journal of the Korean Magnetic Resonance Society 14:2, 88-104
    CrossRef

  63. 63

    Yi Huang, Yan Wang, Daqian He, Yiping Liu. (2010) Genetic Diversity of the Melanocortin 4 Receptor (MC4R) Gene and its Association with Slaughter Traits in the Landes Goose. Biochemical Genetics 48:11-12, 944-953
    CrossRef

  64. 64

    Alexandra I. F. Blakemore, Philippe Froguel. (2010) Investigation of Mendelian forms of obesity holds out the prospect of personalized medicine. Annals of the New York Academy of Sciences 1214:1, 180-189
    CrossRef

  65. 65

    P. Russo, F. Lauria, A. Siani. (2010) Heritability of body weight: Moving beyond genetics. Nutrition, Metabolism and Cardiovascular Diseases 20:10, 691-697
    CrossRef

  66. 66

    Elizabeth K Speliotes, Cristen J Willer, Sonja I Berndt, Keri L Monda, Gudmar Thorleifsson, Anne U Jackson, Hana Lango Allen, Cecilia M Lindgren, Jian'an Luan, Reedik Mägi, Joshua C Randall, Sailaja Vedantam, Thomas W Winkler, Lu Qi, Tsegaselassie Workalemahu, Iris M Heid, Valgerdur Steinthorsdottir, Heather M Stringham, Michael N Weedon, Eleanor Wheeler, Andrew R Wood, Teresa Ferreira, Robert J Weyant, Ayellet V Segrè, Karol Estrada, Liming Liang, James Nemesh, Ju-Hyun Park, Stefan Gustafsson, Tuomas O Kilpeläinen, Jian Yang, Nabila Bouatia-Naji, Tõnu Esko, Mary F Feitosa, Zoltán Kutalik, Massimo Mangino, Soumya Raychaudhuri, Andre Scherag, Albert Vernon Smith, Ryan Welch, Jing Hua Zhao, Katja K Aben, Devin M Absher, Najaf Amin, Anna L Dixon, Eva Fisher, Nicole L Glazer, Michael E Goddard, Nancy L Heard-Costa, Volker Hoesel, Jouke-Jan Hottenga, Åsa Johansson, Toby Johnson, Shamika Ketkar, Claudia Lamina, Shengxu Li, Miriam F Moffatt, Richard H Myers, Narisu Narisu, John R B Perry, Marjolein J Peters, Michael Preuss, Samuli Ripatti, Fernando Rivadeneira, Camilla Sandholt, Laura J Scott, Nicholas J Timpson, Jonathan P Tyrer, Sophie van Wingerden, Richard M Watanabe, Charles C White, Fredrik Wiklund, Christina Barlassina, Daniel I Chasman, Matthew N Cooper, John-Olov Jansson, Robert W Lawrence, Niina Pellikka, Inga Prokopenko, Jianxin Shi, Elisabeth Thiering, Helene Alavere, Maria T S Alibrandi, Peter Almgren, Alice M Arnold, Thor Aspelund, Larry D Atwood, Beverley Balkau, Anthony J Balmforth, Amanda J Bennett, Yoav Ben-Shlomo, Richard N Bergman, Sven Bergmann, Heike Biebermann, Alexandra I F Blakemore, Tanja Boes, Lori L Bonnycastle, Stefan R Bornstein, Morris J Brown, Thomas A Buchanan, Fabio Busonero, Harry Campbell, Francesco P Cappuccio, Christine Cavalcanti-Proença, Yii-Der Ida Chen, Chih-Mei Chen, Peter S Chines, Robert Clarke, Lachlan Coin, John Connell, Ian N M Day, Martin den Heijer, Jubao Duan, Shah Ebrahim, Paul Elliott, Roberto Elosua, Gudny Eiriksdottir, Michael R Erdos, Johan G Eriksson, Maurizio F Facheris, Stephan B Felix, Pamela Fischer-Posovszky, Aaron R Folsom, Nele Friedrich, Nelson B Freimer, Mao Fu, Stefan Gaget, Pablo V Gejman, Eco J C Geus, Christian Gieger, Anette P Gjesing, Anuj Goel, Philippe Goyette, Harald Grallert, Jürgen Gräßler, Danielle M Greenawalt, Christopher J Groves, Vilmundur Gudnason, Candace Guiducci, Anna-Liisa Hartikainen, Neelam Hassanali, Alistair S Hall, Aki S Havulinna, Caroline Hayward, Andrew C Heath, Christian Hengstenberg, Andrew A Hicks, Anke Hinney, Albert Hofman, Georg Homuth, Jennie Hui, Wilmar Igl, Carlos Iribarren, Bo Isomaa, Kevin B Jacobs, Ivonne Jarick, Elizabeth Jewell, Ulrich John, Torben Jørgensen, Pekka Jousilahti, Antti Jula, Marika Kaakinen, Eero Kajantie, Lee M Kaplan, Sekar Kathiresan, Johannes Kettunen, Leena Kinnunen, Joshua W Knowles, Ivana Kolcic, Inke R König, Seppo Koskinen, Peter Kovacs, Johanna Kuusisto, Peter Kraft, Kirsti Kvaløy, Jaana Laitinen, Olivier Lantieri, Chiara Lanzani, Lenore J Launer, Cecile Lecoeur, Terho Lehtimäki, Guillaume Lettre, Jianjun Liu, Marja-Liisa Lokki, Mattias Lorentzon, Robert N Luben, Barbara Ludwig, Paolo Manunta, Diana Marek, Michel Marre, Nicholas G Martin, Wendy L McArdle, Anne McCarthy, Barbara McKnight, Thomas Meitinger, Olle Melander, David Meyre, Kristian Midthjell, Grant W Montgomery, Mario A Morken, Andrew P Morris, Rosanda Mulic, Julius S Ngwa, Mari Nelis, Matt J Neville, Dale R Nyholt, Christopher J O'Donnell, Stephen O'Rahilly, Ken K Ong, Ben Oostra, Guillaume Paré, Alex N Parker, Markus Perola, Irene Pichler, Kirsi H Pietiläinen, Carl G P Platou, Ozren Polasek, Anneli Pouta, Suzanne Rafelt, Olli Raitakari, Nigel W Rayner, Martin Ridderstråle, Winfried Rief, Aimo Ruokonen, Neil R Robertson, Peter Rzehak, Veikko Salomaa, Alan R Sanders, Manjinder S Sandhu, Serena Sanna, Jouko Saramies, Markku J Savolainen, Susann Scherag, Sabine Schipf, Stefan Schreiber, Heribert Schunkert, Kaisa Silander, Juha Sinisalo, David S Siscovick, Jan H Smit, Nicole Soranzo, Ulla Sovio, Jonathan Stephens, Ida Surakka, Amy J Swift, Mari-Liis Tammesoo, Jean-Claude Tardif, Maris Teder-Laving, Tanya M Teslovich, John R Thompson, Brian Thomson, Anke Tönjes, Tiinamaija Tuomi, Joyce B J van Meurs, Gert-Jan van Ommen, Vincent Vatin, Jorma Viikari, Sophie Visvikis-Siest, Veronique Vitart, Carla I G Vogel, Benjamin F Voight, Lindsay L Waite, Henri Wallaschofski, G Bragi Walters, Elisabeth Widen, Susanna Wiegand, Sarah H Wild, Gonneke Willemsen, Daniel R Witte, Jacqueline C Witteman, Jianfeng Xu, Qunyuan Zhang, Lina Zgaga, Andreas Ziegler, Paavo Zitting, John P Beilby, I Sadaf Farooqi, Johannes Hebebrand, Heikki V Huikuri, Alan L James, Mika Kähönen, Douglas F Levinson, Fabio Macciardi, Markku S Nieminen, Claes Ohlsson, Lyle J Palmer, Paul M Ridker, Michael Stumvoll, Jacques S Beckmann, Heiner Boeing, Eric Boerwinkle, Dorret I Boomsma, Mark J Caulfield, Stephen J Chanock, Francis S Collins, L Adrienne Cupples, George Davey Smith, Jeanette Erdmann, Philippe Froguel, Henrik Grönberg, Ulf Gyllensten, Per Hall, Torben Hansen, Tamara B Harris, Andrew T Hattersley, Richard B Hayes, Joachim Heinrich, Frank B Hu, Kristian Hveem, Thomas Illig, Marjo-Riitta Jarvelin, Jaakko Kaprio, Fredrik Karpe, Kay-Tee Khaw, Lambertus A Kiemeney, Heiko Krude, Markku Laakso, Debbie A Lawlor, Andres Metspalu, Patricia B Munroe, Willem H Ouwehand, Oluf Pedersen, Brenda W Penninx, Annette Peters, Peter P Pramstaller, Thomas Quertermous, Thomas Reinehr, Aila Rissanen, Igor Rudan, Nilesh J Samani, Peter E H Schwarz, Alan R Shuldiner, Timothy D Spector, Jaakko Tuomilehto, Manuela Uda, André Uitterlinden, Timo T Valle, Martin Wabitsch, Gérard Waeber, Nicholas J Wareham, Hugh Watkins, James F Wilson, Alan F Wright, M Carola Zillikens, Nilanjan Chatterjee, Steven A McCarroll, Shaun Purcell, Eric E Schadt, Peter M Visscher, Themistocles L Assimes, Ingrid B Borecki, Panos Deloukas, Caroline S Fox, Leif C Groop, Talin Haritunians, David J Hunter, Robert C Kaplan, Karen L Mohlke, Jeffrey R O'Connell, Leena Peltonen, David Schlessinger, David P Strachan, Cornelia M van Duijn, H-Erich Wichmann, Timothy M Frayling, Unnur Thorsteinsdottir, Gonçalo R Abecasis, Inês Barroso, Michael Boehnke, Kari Stefansson, Kari E North, Mark I McCarthy, Joel N Hirschhorn, Erik Ingelsson, Ruth J F Loos. (2010) Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nature Genetics 42:11, 937-948
    CrossRef

  67. 67

    G.A. Kennett, P.G. Clifton. (2010) New approaches to the pharmacological treatment of obesity: Can they break through the efficacy barrier?. Pharmacology Biochemistry and Behavior 97:1, 63-83
    CrossRef

  68. 68

    M Rosenbaum, R L Leibel. (2010) Adaptive thermogenesis in humans. International Journal of Obesity 34, S47-S55
    CrossRef

  69. 69

    I. Hochberg, Z. Hochberg. (2010) Expanding the definition of hypothalamic obesity. Obesity Reviews 11:10, 709-721
    CrossRef

  70. 70

    Dennis E. Amundson, Svetolik Djurkovic, Gregory N. Matwiyoff. (2010) The Obesity Paradox. Critical Care Clinics 26:4, 583-596
    CrossRef

  71. 71

    Yu. A. Pankov. (2010) Genetic variations in the regulation of energy balance. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry 4:3, 213-223
    CrossRef

  72. 72

    T. L. Horvath, B. Sarman, C. Garcia-Caceres, P. J. Enriori, P. Sotonyi, M. Shanabrough, E. Borok, J. Argente, J. A. Chowen, D. Perez-Tilve, P. T. Pfluger, H. S. Bronneke, B. E. Levin, S. Diano, M. A. Cowley, M. H. Tschop. (2010) Synaptic input organization of the melanocortin system predicts diet-induced hypothalamic reactive gliosis and obesity. Proceedings of the National Academy of Sciences 107:33, 14875-14880
    CrossRef

  73. 73

    Marion L. Vetter, Lucy F. Faulconbridge, Victoria L. Webb, Thomas A. Wadden. (2010) Behavioral and pharmacologic therapies for obesity. Nature Reviews Endocrinology
    CrossRef

  74. 74

    M. J. Müller, A. Bosy-Westphal, M. Krawczak. (2010) Genetic studies of common types of obesity: a critique of the current use of phenotypes. Obesity Reviews 11:8, 612-618
    CrossRef

  75. 75

    Kenneth J. Valenzano, Elfrida R. Benjamin, Patricia René, Michel Bouvier. 2010. Pharmacological Chaperones: Potential for the Treatment of Hereditary Diseases Caused by Mutations in G Protein-Coupled Receptors. , 460-510.
    CrossRef

  76. 76

    George A. Bray. 2010. Control of Weight: How Do We Get Fat?. , 126-137.
    CrossRef

  77. 77

    J. Hebebrand, K. Bammann, A. Hinney. (2010) Genetische Ursachen der Adipositas. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 53:7, 674-680
    CrossRef

  78. 78

    A.M. Obregón, P. Amador, M. Valladares, G. Weisstaub, R. Burrows, J.L. Santos. (2010) Melanocortin-3 receptor gene variants: Association with childhood obesity and eating behavior in Chilean families. Nutrition 26:7-8, 760-765
    CrossRef

  79. 79

    Lucas Doedens, Florian Opperer, Minying Cai, Johannes G. Beck, Matt Dedek, Erin Palmer, Victor J. Hruby, Horst Kessler. (2010) Multiple N -Methylation of MT-II Backbone Amide Bonds Leads to Melanocortin Receptor Subtype hMC1R Selectivity: Pharmacological and Conformational Studies. Journal of the American Chemical Society 132:23, 8115-8128
    CrossRef

  80. 80

    Kathleen G. Mountjoy. (2010) Functions for pro-opiomelanocortin-derived peptides in obesity and diabetes. Biochemical Journal 428:3, 305-324
    CrossRef

  81. 81

    N R Lenard, H Zheng, H-R Berthoud. (2010) Chronic suppression of μ-opioid receptor signaling in the nucleus accumbens attenuates development of diet-induced obesity in rats. International Journal of Obesity 34:6, 1001-1010
    CrossRef

  82. 82

    Andreina Alfieri, Fabrizio Pasanisi, Salvatore Salzano, Luciana Esposito, Domenico Martone, Domenico Tafuri, Aurora Daniele, Franco Contaldo, Lucia Sacchetti, Adriana Zagari, Pasqualina Buono. (2010) Functional analysis of melanocortin-4-receptor mutants identified in severely obese subjects living in Southern Italy. Gene 457:1-2, 35-41
    CrossRef

  83. 83

    Tracy E Hunley, Li-Jun Ma, Valentina Kon. (2010) Scope and mechanisms of obesity-related renal disease. Current Opinion in Nephrology and Hypertension 19:3, 227-234
    CrossRef

  84. 84

    Colleen Keller, Linda Larkey, Johanna K. Distefano, Edna Boehm-Smith, Kathie Records, Alyssa Robillard, Sharry Veres, Manal Al-Zadjali, Anne-Marie O'Brian. (2010) Perimenopausal Obesity. Journal of Women's Health 19:5, 987-996
    CrossRef

  85. 85

    M. Valladares, P. Domínguez-Vásquez, A.M. Obregón, G. Weisstaub, R. Burrows, A. Maiz, J.L. Santos. (2010) Melanocortin-4 receptor gene variants in Chilean families: association with childhood obesity and eating behavior. Nutritional Neuroscience 13:2, 71-78
    CrossRef

  86. 86

    Gaifen Liu, Haidong Zhu, Vasiliki Lagou, Bernard Gutin, Paule Barbeau, Frank A. Treiber, Yanbin Dong, Harold Snieder. (2010) Common Variants Near Melanocortin 4 Receptor Are Associated with General and Visceral Adiposity in European- and African-American Youth. The Journal of Pediatrics 156:4, 598-605.e1
    CrossRef

  87. 87

    Eduardo A. Nillni. (2010) Regulation of the hypothalamic Thyrotropin Releasing Hormone (TRH) neuron by neuronal and peripheral inputs. Frontiers in Neuroendocrinology 31:2, 134-156
    CrossRef

  88. 88

    Thomas Kung, Jochen Springer, Wolfram Doehner, Stefan D Anker, Stephan von Haehling. (2010) Novel treatment approaches to cachexia and sarcopenia: highlights from the 5th Cachexia Conference. Expert Opinion on Investigational Drugs 19:4, 579-585
    CrossRef

  89. 89

    Catherine S. Mitchell, David B. Savage, Sylvie Dufour, Nadia Schoenmakers, Peter Murgatroyd, Douglas Befroy, David Halsall, Samantha Northcott, Philippa Raymond-Barker, Suzanne Curran, Elana Henning, Julia Keogh, Penny Owen, John Lazarus, Douglas L. Rothman, I. Sadaf Farooqi, Gerald I. Shulman, Krishna Chatterjee, Kitt Falk Petersen. (2010) Resistance to thyroid hormone is associated with raised energy expenditure, muscle mitochondrial uncoupling, and hyperphagia. Journal of Clinical Investigation 120:4, 1345-1354
    CrossRef

  90. 90

    I. Dankwa-Mullan, K. B. Rhee, D. M. Stoff, J. R. Pohlhaus, F. S. Sy, N. Stinson, J. Ruffin. (2010) Moving Toward Paradigm-Shifting Research in Health Disparities Through Translational, Transformational, and Transdisciplinary Approaches. American Journal of Public Health 100:S1, S19-S24
    CrossRef

  91. 91

    T. Maier, J. Hoyer. (2010) Modulation of blood pressure by central melanocortinergic pathways. Nephrology Dialysis Transplantation 25:3, 674-677
    CrossRef

  92. 92

    Anke Hinney, Carla I. G. Vogel, Johannes Hebebrand. (2010) From monogenic to polygenic obesity: recent advances. European Child & Adolescent Psychiatry 19:3, 297-310
    CrossRef

  93. 93

    R. Nogueiras, M. López, C. Diéguez. (2010) Regulation of lipid metabolism by energy availability: a role for the central nervous system. Obesity Reviews 11:3, 185-201
    CrossRef

  94. 94

    Du Wang, Jun Ma, Su Zhang, Anke Hinney, Johannes Hebebrand, Yan Wang, Hai-Jun Wang. (2010) Association of the MC4R V103I Polymorphism With Obesity: A Chinese Case–control Study and Meta-analysis in 55,195 Individuals. Obesity 18:3, 573-579
    CrossRef

  95. 95

    Elena G. Bochukova, Ni Huang, Julia Keogh, Elana Henning, Carolin Purmann, Kasia Blaszczyk, Sadia Saeed, Julian Hamilton-Shield, Jill Clayton-Smith, Stephen O’Rahilly, Matthew E. Hurles, I. Sadaf Farooqi. (2010) Large, rare chromosomal deletions associated with severe early-onset obesity. Nature 463:7281, 666-670
    CrossRef

  96. 96

    Mark Daniel DeBoer. (2010) Update on melanocortin interventions for cachexia: Progress toward clinical application. Nutrition 26:2, 146-151
    CrossRef

  97. 97

    Christian L. Roth, Pablo J. Enriori, Ursel Gebhardt, Anke Hinney, Hermann L. Müller, Johannes Hebebrand, Thomas Reinehr, Michael A. Cowley. (2010) Changes of peripheral α-melanocyte–stimulating hormone in childhood obesity. Metabolism 59:2, 186-194
    CrossRef

  98. 98

    R. Hardy, A. K. Wills, A. Wong, C. E. Elks, N. J. Wareham, R. J.F. Loos, D. Kuh, K. K. Ong. (2010) Life course variations in the associations between FTO and MC4R gene variants and body size. Human Molecular Genetics 19:3, 545-552
    CrossRef

  99. 99

    Karani S. Vimaleswaran, Ruth J.F. Loos. (2010) Progress in the genetics of common obesity and type 2 diabetes. Expert Reviews in Molecular Medicine 12,
    CrossRef

  100. 100

    Latonya F. Been, Swapan K. Nath, Sarju K. Ralhan, Gurpreet S. Wander, Narinder K. Mehra, Jairup Singh, John J. Mulvihill, Dharambir K. Sanghera. (2010) Replication of Association Between a Common Variant Near Melanocortin-4 Receptor Gene and Obesity-related Traits in Asian Sikhs. Obesity 18:2, 425-429
    CrossRef

  101. 101

    Tsutomu Sasaki, Tadahiro Kitamura. (2010) Roles of FoxO1 and Sirt1 in the central regulation of food intake. Endocrine Journal 57:11, 939-946
    CrossRef

  102. 102

    L S Weinstein, T Xie, A Qasem, J Wang, M Chen. (2010) The role of GNAS and other imprinted genes in the development of obesity. International Journal of Obesity 34:1, 6-17
    CrossRef

  103. 103

    S I I Kring, C Holst, S Toubro, A Astrup, T Hansen, O Pedersen, T I A Sørensen. (2010) Common variants near MC4R in relation to body fat, body fat distribution, metabolic traits and energy expenditure. International Journal of Obesity 34:1, 182-189
    CrossRef

  104. 104

    E. Stokić, M. Djan, Lj Vapa, I. Djan, A. Plećaš, B. Srdić. (2010) Polymorphism Val103Ile of the melanocortin-4 receptor gene in the Serbian population. Molecular Biology Reports 37:1, 33-37
    CrossRef

  105. 105

    B.E. Grayson, P. Kievit, M.S. Smith, K.L. Grove. (2010) Critical determinants of hypothalamic appetitive neuropeptide development and expression: Species considerations. Frontiers in Neuroendocrinology 31:1, 16-31
    CrossRef

  106. 106

    Beatrice Dubern, Patrick Tounian, Karine Clément. 2010. Obesity. , 27-324.
    CrossRef

  107. 107

    R Krishna, B Gumbiner, C Stevens, B Musser, M Mallick, S Suryawanshi, L Maganti, H Zhu, T H Han, L Scherer, B Simpson, D Cosgrove, K Gottesdiener, J Amatruda, B J Rolls, J Blundell, G A Bray, K Fujioka, S B Heymsfield, J A Wagner, G A Herman. (2009) Potent and Selective Agonism of the Melanocortin Receptor 4 With MK-0493 Does Not Induce Weight Loss in Obese Human Subjects: Energy Intake Predicts Lack of Weight Loss Efficacy. Clinical Pharmacology &#38; Therapeutics 86:6, 659-666
    CrossRef

  108. 108

    Ruth J. F. Loos. (2009) Recent progress in the genetics of common obesity. British Journal of Clinical Pharmacology 68:6, 811-829
    CrossRef

  109. 109

    J Kettunen, M Perola, N G Martin, B K Cornes, S G Wilson, G W Montgomery, B Benyamin, J R Harris, D Boomsma, G Willemsen, J-J Hottenga, P E Slagboom, K Christensen, K O Kyvik, T I A Sørensen, N L Pedersen, P K E Magnusson, T Andrew, T D Spector, E Widen, K Silventoinen, J Kaprio, A Palotie, L Peltonen. (2009) Multicenter dizygotic twin cohort study confirms two linkage susceptibility loci for body mass index at 3q29 and 7q36 and identifies three further potential novel loci. International Journal of Obesity 33:11, 1235-1242
    CrossRef

  110. 110

    Elizabeth K. Speliotes. (2009) The genetic determinants of common human obesity. Current Cardiovascular Risk Reports 3:6, 411-417
    CrossRef

  111. 111

    A. J. Stunkard, K. C. Allison, J. D. Lundgren, J. P. O'Reardon. (2009) A biobehavioural model of the night eating syndrome. Obesity Reviews 10, 69-77
    CrossRef

  112. 112

    2009. References. , 335-389.
    CrossRef

  113. 113

    Camilla H. Andreasen, Gitte Andersen. (2009) Gene–environment interactions and obesity—Further aspects of genomewide association studies. Nutrition 25:10, 998-1003
    CrossRef

  114. 114

    Melissa K. Crocker, Jack A. Yanovski. (2009) Pediatric Obesity: Etiology and Treatment. Endocrinology & Metabolism Clinics of North America 38:3, 525-548
    CrossRef

  115. 115

    F. M. Finucane. (2009) Obesity in Irish youth: epidemiology and implications. Irish Journal of Medical Science 178:3, 249-255
    CrossRef

  116. 116

    A. J. de Smith, C. Purmann, R. G. Walters, R. J. Ellis, S. E. Holder, M. M. Van Haelst, A. F. Brady, U. L. Fairbrother, M. Dattani, J. M. Keogh, E. Henning, G. S.H. Yeo, S. O'Rahilly, P. Froguel, I. S. Farooqi, A. I.F. Blakemore. (2009) A deletion of the HBII-85 class of small nucleolar RNAs (snoRNAs) is associated with hyperphagia, obesity and hypogonadism. Human Molecular Genetics 18:17, 3257-3265
    CrossRef

  117. 117

    Zhen-Chuan Fan, Ya-Xiong Tao. (2009) Functional characterization and pharmacological rescue of melanocortin-4 receptor mutations identified from obese patients. Journal of Cellular and Molecular Medicine 13:9b, 3268-3282
    CrossRef

  118. 118

    Christian L. Roth, Michael Ludwig, Joachim Woelfle, Zhen-Chuan Fan, Harald Brumm, Heike Biebermann, Ya-Xiong Tao. (2009) A novel melanocortin-4 receptor gene mutation in a female patient with severe childhood obesity. Endocrine 36:1, 52-59
    CrossRef

  119. 119

    A. Marti, J.L. Santos, M. Gratacos, M.J. Moreno-Aliaga, A. Maiz, J.A. Martinez, X. Estivill. (2009) Association between leptin receptor (LEPR) and brain-derived neurotrophic factor (BDNF) gene variants and obesity: a case-control study. Nutritional Neuroscience 12:4, 183-188
    CrossRef

  120. 120

    Alexandra I.F. Blakemore, David Meyre, Jerome Delplanque, Vincent Vatin, Cecile Lecoeur, Michel Marre, Jean Tichet, Beverley Balkau, Philippe Froguel, Andrew J. Walley. (2009) A Rare Variant in the Visfatin Gene (NAMPT/PBEF1) Is Associated With Protection From Obesity. Obesity 17:8, 1549-1553
    CrossRef

  121. 121

    I. Sadaf Farooqi. 2009. Weight Regulation and Monogenic Obesity. , 571-577.
    CrossRef

  122. 122

    B. Benelam. (2009) Satiation, satiety and their effects on eating behaviour. Nutrition Bulletin 34:2, 126-173
    CrossRef

  123. 123

    Florian Bolze, M. Klingenspor. (2009) Mouse models for the central melanocortin system. Genes & Nutrition 4:2, 129-134
    CrossRef

  124. 124

    Yingkui Yang, Minying Cai, Min Chen, Hongchang Qu, David McPherson, Victor Hruby, Carroll M. Harmon. (2009) Key amino acid residues in the melanocortin-4 receptor for nonpeptide THIQ specific binding and signaling. Regulatory Peptides 155:1-3, 46-54
    CrossRef

  125. 125

    Nathan F. Bradford. (2009) Overweight and Obesity in Children and Adolescents. Primary Care: Clinics in Office Practice 36:2, 319-339
    CrossRef

  126. 126

    Elizabeth K. Speliotes. (2009) Genetics of Common Obesity and Nonalcoholic Fatty Liver Disease. Gastroenterology 136:5, 1492-1495
    CrossRef

  127. 127

    L. F. Chan, T. R. Webb, T.-T. Chung, E. Meimaridou, S. N. Cooray, L. Guasti, J. P. Chapple, M. Egertova, M. R. Elphick, M. E. Cheetham, L. A. Metherell, A. J. L. Clark. (2009) MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family. Proceedings of the National Academy of Sciences 106:15, 6146-6151
    CrossRef

  128. 128

    Paolo Magni, Elena Dozio, Massimiliano Ruscica, Fabio Celotti, Maria Angela Masini, Paola Prato, Marco Broccoli, Andrea Mambro, Massimo Morè, Felice Strollo. (2009) Feeding Behavior in Mammals Including Humans. Annals of the New York Academy of Sciences 1163:1, 221-232
    CrossRef

  129. 129

    Robert E. Kramer, Stephen R. Daniels. (2009) Evaluation of a child for secondary causes of obesity and comorbidities. Nature Reviews Endocrinology 5:4, 227-232
    CrossRef

  130. 130

    F Stutzmann, S Cauchi, E Durand, C Calvacanti-Proença, M Pigeyre, A-L Hartikainen, U Sovio, J Tichet, M Marre, J Weill, B Balkau, N Potoczna, J Laitinen, P Elliott, M-R Järvelin, F Horber, D Meyre, P Froguel. (2009) Common genetic variation near MC4R is associated with eating behaviour patterns in European populations. International Journal of Obesity 33:3, 373-378
    CrossRef

  131. 131

    A Tenesa, H Campbell, E Theodoratou, L Dunlop, R Cetnarskyj, S M Farrington, M G Dunlop. (2009) Common genetic variants at the MC4R locus are associated with obesity, but not with dietary energy intake or colorectal cancer in the Scottish population. International Journal of Obesity 33:2, 284-288
    CrossRef

  132. 132

    Juliana Austin, Daniel Marks. (2009) Hormonal Regulators of Appetite. International Journal of Pediatric Endocrinology 2009, 1-9
    CrossRef

  133. 133

    A C M Heinsbroek, G van Dijk. (2009) Gestational weight gain by reduced brain melanocortin activity affects offspring energy balance in rats. International Journal of Obesity 33:1, 104-114
    CrossRef

  134. 134

    David A. Hughes, Anke Hinney, Harald Brumm, Anne-Kathrin Wermter, Heike Biebermann, Johannes Hebebrand, Mark Stoneking. (2009) Increased constraints on MC4R during primate and human evolution. Human Genetics 124:6, 633-647
    CrossRef

  135. 135

    William T. Donahoo, Teri L. Hernandez, Jessica L. Costa, Dalan R. Jensen, Alison M. Morris, Miles B. Brennan, Ute Hochgeschwender, Robert H. Eckel. (2009) Plasma α–melanocyte-stimulating hormone: sex differences and correlations with obesity. Metabolism 58:1, 16-21
    CrossRef

  136. 136

    Juliana Austin, Daniel Marks. (2009) Hormonal Regulators of Appetite. International Journal of Pediatric Endocrinology 2009:1, 141753
    CrossRef

  137. 137

    Greenfield, Jerry R., Miller, Jeffrey W., Keogh, Julia M., Henning, Elana, Satterwhite, Julie H., Cameron, Gregory S., Astruc, Beatrice, Mayer, John P., Brage, Soren, See, Teik Choon, Lomas, David J., O'Rahilly, Stephen, Farooqi, I. Sadaf, . (2009) Modulation of Blood Pressure by Central Melanocortinergic Pathways. New England Journal of Medicine 360:1, 44-52
    Full Text

  138. 138

    Leibel, Rudolph L., . (2008) Energy In, Energy Out, and the Effects of Obesity-Related Genes. New England Journal of Medicine 359:24, 2603-2604
    Full Text

  139. 139

    Anat Agranat-Meged, Yoad Ghanadri, Iris Eisenberg, Ziva Ben Neriah, Eva Kieselstein-Gross, Stella Mitrani-Rosenbaum. (2008) Attention deficit hyperactivity disorder in obese melanocortin-4-receptor (MC4R) deficient subjects: A newly described expression of MC4R deficiency. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 147B:8, 1547-1553
    CrossRef

  140. 140

    S O'Rahilly, I S Farooqi. (2008) Human obesity as a heritable disorder of the central control of energy balance. International Journal of Obesity 32, S55-S61
    CrossRef

  141. 141

    R L Leibel. (2008) Molecular physiology of weight regulation in mice and humans. International Journal of Obesity 32, S98-S108
    CrossRef

  142. 142

    Shoko Kawashima, Satoru Sakihara, Kazunori Kageyama, Takeshi Nigawara, Toshihiro Suda. (2008) Corticotropin-releasing factor (CRF) is involved in the acute anorexic effect of α-melanocyte-stimulating hormone: A study using CRF-deficient mice. Peptides 29:12, 2169-2174
    CrossRef

  143. 143

    Thomas Reinehr, Johannes Hebebrand, Susann Friedel, André M. Toschke, Harald Brumm, Heike Biebermann, Anke Hinney. (2008) Lifestyle Intervention in Obese Children With Variations in the Melanocortin 4 Receptor Gene. Obesity
    CrossRef

  144. 144

    Palmiero Monteleone, Mario Maj. (2008) Genetic susceptibility to eating disorders: associated polymorphisms and pharmacogenetic suggestions. Pharmacogenomics 9:10, 1487-1520
    CrossRef

  145. 145

    I Sadaf Farooqi, Stephen O'Rahilly. (2008) Mutations in ligands and receptors of the leptin–melanocortin pathway that lead to obesity. Nature Clinical Practice Endocrinology &#38; Metabolism 4:10, 569-577
    CrossRef

  146. 146

    M. Baltatzi, A. Hatzitolios, K. Tziomalos, F. Iliadis, Ch. Zamboulis. (2008) Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension. International Journal of Clinical Practice 62:9, 1432-1440
    CrossRef

  147. 147

    Karl G. Hofbauer, Anne-Catherine Lecourt, Jean-Christophe Peter. (2008) Antibodies as pharmacologic tools for studies on the regulation of energy balance. Nutrition 24:9, 791-797
    CrossRef

  148. 148

    Katherine A Simpson, Niamh M Martin, Steve R Bloom. (2008) Hypothalamic regulation of appetite. Expert Review of Endocrinology & Metabolism 3:5, 577-592
    CrossRef

  149. 149

    T Jess, E Zimmermann, S I I Kring, T Berentzen, C Holst, S Toubro, A Astrup, T Hansen, O Pedersen, T I A Sørensen. (2008) Impact on weight dynamics and general growth of the common FTO rs9939609: a longitudinal Danish cohort study. International Journal of Obesity 32:9, 1388-1394
    CrossRef

  150. 150

    Sayali A. Ranadive, Christian Vaisse. (2008) Lessons from Extreme Human Obesity: Monogenic Disorders. Endocrinology & Metabolism Clinics of North America 37:3, 733-751
    CrossRef

  151. 151

    J. L. Santos, P. Amador, M. Valladares, C. Albala, J. A. Martínez, A. Marti. (2008) Obesity and eating behaviour in a three-generation chilean family with carriers of the Thr150Ile mutation in the melanocortin-4 receptor gene. Journal of Physiology and Biochemistry 64:3, 205-210
    CrossRef

  152. 152

    Regina C. Casper, Elinor L. Sullivan, Laurence Tecott. (2008) Relevance of animal models to human eating disorders and obesity. Psychopharmacology 199:3, 313-329
    CrossRef

  153. 153

    Ruth McPherson. (2008) Beyond calories: Genetic determinants of eating, satiety and metabolism underlying obesity. Canadian Journal of Cardiology 24, 15C-17C
    CrossRef

  154. 154

    John RB Perry, Timothy M Frayling. (2008) New gene variants alter type 2 diabetes risk predominantly through reduced beta-cell function. Current Opinion in Clinical Nutrition and Metabolic Care 11:4, 371-377
    CrossRef

  155. 155

    Ruth J F Loos, Cecilia M Lindgren, Shengxu Li, Eleanor Wheeler, Jing Hua Zhao, Inga Prokopenko, Michael Inouye, Rachel M Freathy, Antony P Attwood, Jacques S Beckmann, Sonja I Berndt, Kevin B Jacobs, Stephen J Chanock, Richard B Hayes, Sven Bergmann, Amanda J Bennett, Sheila A Bingham, Murielle Bochud, Morris Brown, Stéphane Cauchi, John M Connell, Cyrus Cooper, George Davey Smith, Ian Day, Christian Dina, Subhajyoti De, Emmanouil T Dermitzakis, Alex S F Doney, Katherine S Elliott, Paul Elliott, David M Evans, I Sadaf Farooqi, Philippe Froguel, Jilur Ghori, Christopher J Groves, Rhian Gwilliam, David Hadley, Alistair S Hall, Andrew T Hattersley, Johannes Hebebrand, Iris M Heid, Claudia Lamina, Christian Gieger, Thomas Illig, Thomas Meitinger, H-Erich Wichmann, Blanca Herrera, Anke Hinney, Sarah E Hunt, Marjo-Riitta Jarvelin, Toby Johnson, Jennifer D M Jolley, Fredrik Karpe, Andrew Keniry, Kay-Tee Khaw, Robert N Luben, Massimo Mangino, Jonathan Marchini, Wendy L McArdle, Ralph McGinnis, David Meyre, Patricia B Munroe, Andrew D Morris, Andrew R Ness, Matthew J Neville, Alexandra C Nica, Ken K Ong, Stephen O'Rahilly, Katharine R Owen, Colin N A Palmer, Konstantinos Papadakis, Simon Potter, Anneli Pouta, Lu Qi, Peter Kraft, Susan E Hankinson, David J Hunter, Frank B Hu, Joshua C Randall, Nigel W Rayner, Susan M Ring, Manjinder S Sandhu, André Scherag, Matthew A Sims, Kijoung Song, Nicole Soranzo, Elizabeth K Speliotes, Helen N Lyon, Benjamin F Voight, Martin Ridderstrale, Leif Groop, Holly E Syddall, Sarah A Teichmann, Nicholas J Timpson, Jonathan H Tobias, Manuela Uda, Paul Scheet, Serena Sanna, Goncalo R Abecasis, Giuseppe Albai, Ramaiah Nagaraja, David Schlessinger, Carla I Ganz Vogel, Chris Wallace, Dawn M Waterworth, Michael N Weedon, Cristen J Willer, Anne U Jackson, Jaakko Tuomilehto, Francis S Collins, Michael Boehnke, Karen L Mohlke, Vicki L Wraight, Xin Yuan, Eleftheria Zeggini, Joel N Hirschhorn, David P Strachan, Willem H Ouwehand, Mark J Caulfield, Nilesh J Samani, Timothy M Frayling, Peter Vollenweider, Gerard Waeber, Vincent Mooser, Panos Deloukas, Mark I McCarthy, Nicholas J Wareham, Inês Barroso. (2008) Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nature Genetics 40:6, 768-775
    CrossRef

  156. 156

    John C Chambers, Paul Elliott, Delilah Zabaneh, Weihua Zhang, Yun Li, Philippe Froguel, David Balding, James Scott, Jaspal S Kooner. (2008) Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nature Genetics 40:6, 716-718
    CrossRef

  157. 157

    Zhen-Chuan Fan, James L. Sartin, Ya-Xiong Tao. (2008) Pharmacological analyses of two naturally occurring porcine melanocortin-4 receptor mutations in domestic pigs. Domestic Animal Endocrinology 34:4, 383-390
    CrossRef

  158. 158

    Monica Mencarelli, Gillian E Walker, Sabrina Maestrini, Luisella Alberti, Barbara Verti, Amelia Brunani, Maria Letizia Petroni, Mariantonella Tagliaferri, Antonio Liuzzi, Anna Maria Di Blasio. (2008) Sporadic mutations in melanocortin receptor 3 in morbid obese individuals. European Journal of Human Genetics 16:5, 581-586
    CrossRef

  159. 159

    Aamir R. Zuberi, Leigh Townsend, Laurel Patterson, Huiyuan Zheng, Hans-Rudi Berthoud. (2008) Increased adiposity on normal diet, but decreased susceptibility to diet-induced obesity in μ-opioid receptor-deficient mice. European Journal of Pharmacology 585:1, 14-23
    CrossRef

  160. 160

    Ruben Nogueiras, Matthias H. Tschöp, Jeffrey M. Zigman. (2008) Central Nervous System Regulation of Energy Metabolism. Annals of the New York Academy of Sciences 1126:1, 14-19
    CrossRef

  161. 161

    Yung Seng Lee, Larry Kok Seng Poh, Betty Lay Kee Kek, Kah Yin Loke. (2008) Novel melanocortin 4 receptor gene mutations in severely obese children. Clinical Endocrinology 68:4, 529-535
    CrossRef

  162. 162

    Shengxu Li, Ruth JF Loos. (2008) Progress in the genetics of common obesity: size matters. Current Opinion in Lipidology 19:2, 113-121
    CrossRef

  163. 163

    Jennifer L. Miller, Anthony P. Goldstone, Jessica A. Couch, Jonathan Shuster, Guojun He, Daniel J. Driscoll, Yijun Liu, Ilona M. Schmalfuss. (2008) Pituitary abnormalities in Prader–Willi syndrome and early onset morbid obesity. American Journal of Medical Genetics Part A 146A:5, 570-577
    CrossRef

  164. 164

    Iris M. Heid, Caren Vollmert, Florian Kronenberg, Cornelia Huth, Donna P. Ankerst, Andreas Luchner, Anke Hinney, Günter Brönner, H.-E. Wichmann, Thomas Illig, Angela Döring, Johannes Hebebrand. (2008) Association of the MC4R V103I Polymorphism With the Metabolic Syndrome: The KORA Study. Obesity 16:2, 369-376
    CrossRef

  165. 165

    Elena Valassi, Massimo Scacchi, Francesco Cavagnini. (2008) Neuroendocrine control of food intake. Nutrition, Metabolism and Cardiovascular Diseases 18:2, 158-168
    CrossRef

  166. 166

    Anthony N. Hollenberg. (2008) The Role of the Thyrotropin-Releasing Hormone (TRH) Neuron as a Metabolic Sensor. Thyroid 18:2, 131-139
    CrossRef

  167. 167

    Stefan Knecht, Tanja Ellger, James A. Levine. (2008) Obesity in neurobiology. Progress in Neurobiology 84:1, 85-103
    CrossRef

  168. 168

    Do-Hun Kim, Seung Woo Shin, Ja-Hyun Baik. (2008) Role of third intracellular loop of the melanocortin 4 receptor in the regulation of constitutive activity. Biochemical and Biophysical Research Communications 365:3, 439-445
    CrossRef

  169. 169

    ROBERT H. LUSTIG, RAM WEISS. 2008. Disorders of Energy Balance. , 788-838.
    CrossRef

  170. 170

    ALAN M. RICE, SCOTT A. RIVKEES. 2008. Receptor Transduction of Hormone Action. , 26-73.
    CrossRef

  171. 171

    M. Pigeyre, M. Romon. (2007) Obésités génétiques. Annales d'Endocrinologie 68:6, 430-437
    CrossRef

  172. 172

    J. R. Nicholson, J.-C. Peter, A.-C. Lecourt, Y.-A. Barde, K. G. Hofbauer. (2007) Melanocortin-4 Receptor Activation Stimulates Hypothalamic Brain-Derived Neurotrophic Factor Release to Regulate Food Intake, Body Temperature and Cardiovascular Function. Journal of Neuroendocrinology 19:12, 974-982
    CrossRef

  173. 173

    Christopher D. Morrison, Hans-Rudolf Berthoud. (2007) Neurobiology of Nutrition and Obesity. Nutrition Reviews 65:12, 517-534
    CrossRef

  174. 174

    Ruben Nogueiras, Petra Wiedmer, Diego Perez-Tilve, Christelle Veyrat-Durebex, Julia M. Keogh, Gregory M. Sutton, Paul T. Pfluger, Tamara R. Castaneda, Susanne Neschen, Susanna M. Hofmann, Philip N. Howles, Donald A. Morgan, Stephen C. Benoit, Ildiko Szanto, Brigitte Schrott, Annette Schürmann, Hans-Georg Joost, Craig Hammond, David Y. Hui, Stephen C. Woods, Kamal Rahmouni, Andrew A. Butler, I. Sadaf Farooqi, Stephen O’Rahilly, Françoise Rohner-Jeanrenaud, Matthias H. Tschöp. (2007) The central melanocortin system directly controls peripheral lipid metabolism. Journal of Clinical Investigation 117:11, 3475-3488
    CrossRef

  175. 175

    (2007) Effects of a Porcine MC4R Polymorphism(892G>A) on Carcass Traits in Commercial Pigs. Journal of Animal Science and Technology 49:5, 569-576
    CrossRef

  176. 176

    Winfried Rief, Matthias Conradt, Jan-Michael Dierk, Elisabeth Rauh, Pia Schlumberger, Anke Hinney, Johannes Hebebrand. (2007) Is Information on Genetic Determinants of Obesity Helpful or Harmful for Obese People?—A Randomized Clinical Trial. Journal of General Internal Medicine 22:11, 1553-1559
    CrossRef

  177. 177

    AP Russ, J Grosse. (2007) Mouse genetics in drug target discovery and validation: no simple answers to complex problems. Expert Opinion on Drug Discovery 2:10, 1379-1387
    CrossRef

  178. 178

    E H Young, N J Wareham, S Farooqi, A Hinney, J Hebebrand, A Scherag, S O'Rahilly, I Barroso, M S Sandhu. (2007) The V103I polymorphism of the MC4R gene and obesity: population based studies and meta-analysis of 29 563 individuals. International Journal of Obesity 31:9, 1437-1441
    CrossRef

  179. 179

    (2007) Associations of the Porcine Melanocortin-4 Receptor (MC4R) Gene with Growth Traits in Duroc Pigs. Journal of Animal Science and Technology 49:4, 437-442
    CrossRef

  180. 180

    Ruth McPherson. (2007) Genetic contributors to obesity. Canadian Journal of Cardiology 23, 23A-27A
    CrossRef

  181. 181

    Jennifer L. Miller, Jessica A. Couch, Christiana M. Leonard, Krista Schwenk, Stephen D. Towler, Jonathan Shuster, Anthony P. Goldstone, Guojun He, Daniel J. Driscoll, Yijun Liu. (2007) Sylvian fissure morphology in Prader-Willi syndrome and early-onset morbid obesity. Genetics in Medicine 9:8, 536-543
    CrossRef

  182. 182

    M. L. Hart Sailors, A. R. Folsom, C. M. Ballantyne, D. M. Hoelscher, A. S. Jackson, W. H. Linda Kao, J. S. Pankow, M. S. Bray. (2007) Genetic variation and decreased risk for obesity in the Atherosclerosis Risk in Communities Study. Diabetes, Obesity and Metabolism 9:4, 548-557
    CrossRef

  183. 183

    Mark D DeBoer. (2007) Melanocortin interventions in cachexia: how soon from bench to bedside?. Current Opinion in Clinical Nutrition and Metabolic Care 10:4, 457-462
    CrossRef

  184. 184

    A. Oswal, G. S. H. Yeo. (2007) The leptin melanocortin pathway and the control of body weight: lessons from human and murine genetics. Obesity Reviews 8:4, 293-306
    CrossRef

  185. 185

    Béatrice Dubern, Selma Bisbis, Habiba Talbaoui, Johanne Le Beyec, Patrick Tounian, Jean-Marc Lacorte, Karine Clément. (2007) Homozygous Null Mutation of the Melanocortin-4 Receptor and Severe Early-Onset Obesity. The Journal of Pediatrics 150:6, 613-617.e1
    CrossRef

  186. 186

    Gil Yosipovitch, Amy DeVore, Aerlyn Dawn. (2007) Obesity and the skin: Skin physiology and skin manifestations of obesity. Journal of the American Academy of Dermatology 56:6, 901-916
    CrossRef

  187. 187

    Constantina Papoutsakis, George V Dedoussis. (2007) Gene–diet interactions in childhood obesity: paucity of evidence as the epidemic of childhood obesity continues to rise. Personalized Medicine 4:2, 133-146
    CrossRef

  188. 188

    Tomohiro Tanaka, Hiroaki Masuzaki, Shintaro Yasue, Ken Ebihara, Tetsuya Shiuchi, Takako Ishii, Naoki Arai, Masakazu Hirata, Hiroshi Yamamoto, Tatsuya Hayashi, Kiminori Hosoda, Yasuhiko Minokoshi, Kazuwa Nakao. (2007) Central Melanocortin Signaling Restores Skeletal Muscle AMP-Activated Protein Kinase Phosphorylation in Mice Fed a High-Fat Diet. Cell Metabolism 5:5, 395-402
    CrossRef

  189. 189

    Anna Skorczyk, Monika Stachowiak, Izabela Szczerbal, Jolanta Klukowska-Roetzler, Claude Schelling, Gaudenz Dolf, Marek Switonski. (2007) Polymorphism and chromosomal location of the MC4R (melanocortin-4 receptor) gene in the dog and red fox. Gene 392:1-2, 247-252
    CrossRef

  190. 190

    Anthony P. Coll, I. Sadaf Farooqi, Stephen O'Rahilly. (2007) The Hormonal Control of Food Intake. Cell 129:2, 251-262
    CrossRef

  191. 191

    TOMOE KINOSHITA, KEIICHI HANAKI, JUN-ICHI NAGAISHI, YUKI KAWASHIMA, KAORI ADACHI, EIJI NANBA, SUSUMU KANZAKI. (2007) Variation analysis of ? 3 -adrenergic receptor and melanocortin-4 receptor genes in childhood obesity. Pediatrics International 49:2, 133-137
    CrossRef

  192. 192

    Khalid K. Alharbi, Emmanuel Spanakis, Karen Tan, Matt J. Smith, Mohammed A. Aldahmesh, Sandra D. O'Dell, Avan Aihie Sayer, Debbie A. Lawlor, Shah Ebrahim, George Davey Smith, Stephen O'Rahilly, Sadaf Farooqi, Cyrus Cooper, David I.W. Phillips, Ian N.M. Day. (2007) Prevalence and functionality of paucimorphic and private MC4R mutations in a large, unselected European British population, scanned by meltMADGE. Human Mutation 28:3, 294-302
    CrossRef

  193. 193

    Ancha Baranova, Manpreet Randhawa, Mohammed Jarrar, Zobair M Younossi. (2007) Adipokines and melanocortins in the hepatic manifestation of metabolic syndrome: nonalcoholic fatty liver disease. Expert Review of Molecular Diagnostics 7:2, 195-205
    CrossRef

  194. 194

    I. S. Farooqi, S. O?Rahilly. (2007) Genetic factors in human obesity. Obesity Reviews 8:s1, 37-40
    CrossRef

  195. 195

    M.A. Joppa, K.R. Gogas, A.C. Foster, S. Markison. (2007) Central infusion of the melanocortin receptor antagonist agouti-related peptide (AgRP(83-132)) prevents cachexia-related symptoms induced by radiation and colon-26 tumors in mice. Peptides 28:3, 636-642
    CrossRef

  196. 196

    Farooqi, I. Sadaf, Wangensteen, Teresia, Collins, Stephan, Kimber, Wendy, Matarese, Giuseppe, Keogh, Julia M., Lank, Emma, Bottomley, Bill, Lopez-Fernandez, Judith, Ferraz-Amaro, Ivan, Dattani, Mehul T., Ercan, Oya, Myhre, Anne Grethe, Retterstol, Lars, Stanhope, Richard, Edge, Julie A., McKenzie, Sheila, Lessan, Nader, Ghodsi, Maryam, De Rosa, Veronica, Perna, Francesco, Fontana, Silvia, Barroso, Inês, Undlien, Dag E., O'Rahilly, Stephen, . (2007) Clinical and Molecular Genetic Spectrum of Congenital Deficiency of the Leptin Receptor. New England Journal of Medicine 356:3, 237-247
    Full Text

  197. 197

    Matthias Hoch, Alex N. Eberle, Urs Wagner, Christian Bussmann, Thomas Peters, Ralph Peterli. (2007) Expression and Localization of Melanocortin-1 Receptor in Human Adipose Tissues of Severely Obese Patients*. Obesity 15:1, 40-49
    CrossRef

  198. 198

    Sadaf Farooqi. (2007) Insights from the Genetics of Severe Childhood Obesity. Hormone Research 68:5, 5-7
    CrossRef

  199. 199

    A. C. Heijboer, H. Pijl, A. M. Van den Hoek, L. M. Havekes, J. A. Romijn, E. P. M. Corssmit. (2006) Gut?Brain Axis: Regulation of Glucose Metabolism. Journal of Neuroendocrinology 18:12, 883-894
    CrossRef

  200. 200

    Stacy Markison, Alan C. Foster. (2006) Targeting melanocortin receptors for the treatment of obesity. Drug Discovery Today: Therapeutic Strategies 3:4, 569-576
    CrossRef

  201. 201

    R A H Adan, B Tiesjema, J J G Hillebrand, S E Fleur, M J H Kas, M Krom. (2006) The MC4 receptor and control of appetite. British Journal of Pharmacology 149:7, 815-827
    CrossRef

  202. 202

    David M. Mutch, Karine Clément. (2006) Genetics of human obesity. Best Practice & Research Clinical Endocrinology & Metabolism 20:4, 647-664
    CrossRef

  203. 203

    Thomas P. Meehan, Koichi Tabeta, Xin Du, Lanette S. Woodward, Karen Firozi, Bruce Beutler, Monica J. Justice. (2006) Point mutations in the melanocortin-4 receptor cause variable obesity in mice. Mammalian Genome 17:12, 1162-1171
    CrossRef

  204. 204

    C. Vaughan, M. Moore, C. Haskell-Luevano, N.E. Rowland. (2006) Food motivated behavior of melanocortin-4 receptor knockout mice under a progressive ratio schedule. Peptides 27:11, 2829-2835
    CrossRef

  205. 205

    Guowen Cai, Shelley A. Cole, Nancy Butte, Carlos Bacino, Vincent Diego, Karen Tan, Harald H. Göring, Stephen O’Rahilly, I. Sadaf Farooqi, Anthony G. Comuzzie. (2006) A Quantitative Trait Locus on Chromosome 18q for Physical Activity and Dietary Intake in Hispanic Children*. Obesity 14:9, 1596-1604
    CrossRef

  206. 206

    Ya-Xiong Tao. (2006) Inactivating mutations of G protein-coupled receptors and diseases: Structure-function insights and therapeutic implications. Pharmacology & Therapeutics 111:3, 949-973
    CrossRef

  207. 207

    Min Chen, Ahmet Celik, Keith E. Georgeson, Carroll M. Harmon, Yingkui Yang. (2006) Molecular basis of melanocortin-4 receptor for AGRP inverse agonism. Regulatory Peptides 136:1-3, 40-49
    CrossRef

  208. 208

    Rong Rong, Ya-Xiong Tao, Bernard M. Y. Cheung, Aimin Xu, Grace C. N. Cheung, Karen S. L. Lam. (2006) Identification and functional characterization of three novel human melanocortin-4 receptor gene variants in an obese Chinese population. Clinical Endocrinology 65:2, 198-205
    CrossRef

  209. 209

    Hans-Rudolf Berthoud. (2006) Homeostatic and Non-homeostatic Pathways Involved in the Control of Food Intake and Energy Balance. Obesity 14, 197S-200S
    CrossRef

  210. 210

    C. S. Bruun, C. B. Jorgensen, V. H. Nielsen, L. Andersson, M. Fredholm. (2006) Evaluation of the porcine melanocortin 4 receptor (MC4R) gene as a positional candidate for a fatness QTL in a cross between Landrace and Hampshire. Animal Genetics 37:4, 359-362
    CrossRef

  211. 211

    Tuomo Rankinen, Claude Bouchard. (2006) Genetics of Food Intake and Eating Behavior Phenotypes in Humans. Annual Review of Nutrition 26:1, 413-434
    CrossRef

  212. 212

    K CLEMENT. (2006) Genetics of human obesity. Comptes Rendus Biologies 329:8, 608-622
    CrossRef

  213. 213

    S. O'Rahilly, I.S. Farooqi. (2006) Genetics of obesity. Philosophical Transactions of the Royal Society B: Biological Sciences 361:1471, 1095-1105
    CrossRef

  214. 214

    Morris F. White. (2006) Regulating insulin signaling and β -cell function through IRS proteinsThis paper is one of a selection of papers published in this Special Issue, entitled Second Messengers and Phosphoproteins—12th International Conference.. Canadian Journal of Physiology and Pharmacology 84:7, 725-737
    CrossRef

  215. 215

    K. Meidtner, A-K. Wermter, A. Hinney, H. Remschmidt, J. Hebebrand, R. Fries. (2006) Association of the melanocortin 4 receptor with feed intake and daily gain in F2 Mangalitsa x Pietrain pigs. Animal Genetics 37:3, 245-247
    CrossRef

  216. 216

    REIZO BABA, NOBUKO IWAO, MASAAKI KOKETSU, MASAMI NAGASHIMA, HIROSHI INASAKA. (2006) Risk of obesity enhanced by poor physical activity in high school students. Pediatrics International 48:3, 268-273
    CrossRef

  217. 217

    Shin Mizutani, Hiroshi Gomi, Isao Hirayama, Tetsuro Izumi. (2006) Chromosome 2 locus Nidd5 has a potent effect on adiposity in the TSOD mouse. Mammalian Genome 17:5, 375-384
    CrossRef

  218. 218

    Lisa D Madison, Daniel L Marks. (2006) Anticatabolic properties of melanocortin-4 receptor antagonists. Current Opinion in Clinical Nutrition and Metabolic Care 9:3, 196-200
    CrossRef

  219. 219

    Tuomo Rankinen, Aamir Zuberi, Yvon C. Chagnon, S. John Weisnagel, George Argyropoulos, Brandon Walts, Louis Pérusse, Claude Bouchard. (2006) The Human Obesity Gene Map: The 2005 Update. Obesity 14:4, 529-644
    CrossRef

  220. 220

    Courtney J Jolliffe, Ian Janssen. (2006) Vascular risks and management of obesity in children and adolescents. Vascular Health and Risk Management 2:2, 171-187
    CrossRef

  221. 221

    C. Christodoulides, A. Scarda, M. Granzotto, G. Milan, E. Nora, J. Keogh, G. Pergola, H. Stirling, N. Pannacciulli, J. K. Sethi, G. Federspil, A. Vidal-Puig, I. S. Farooqi, S. O’Rahilly, R. Vettor. (2006) WNT10B mutations in human obesity. Diabetologia 49:4, 678-684
    CrossRef

  222. 222

    N M Martin, P A Houston, M Patterson, A Sajedi, D F Carmignac, M A Ghatei, S R Bloom, C J Small. (2006) Abnormalities of the somatotrophic axis in the obese agouti mouse. International Journal of Obesity 30:3, 430-438
    CrossRef

  223. 223

    Bettina Proneth, Zhimin Xiang, Irina D. Pogozheva, Sally A. Litherland, Oleg S. Gorbatyuk, Amanda M. Shaw, William J. Millard, Henry I. Mosberg, Carrie Haskell-Luevano. (2006) Molecular Mechanism of the Constitutive Activation of the L250Q Human Melanocortin-4 Receptor Polymorphism. Chemical Biology <html_ent glyph="@amp;" ascii="&"/> Drug Design 67:3, 215-229
    CrossRef

  224. 224

    I Sadaf Farooqi. (2006) The severely obese patient—a genetic work-up. Nature Clinical Practice Endocrinology &#38; Metabolism 2:3, 172-177
    CrossRef

  225. 225

    Greeshma K. Shetty, Christos S. Mantzoros. 2006. Insulin Resistance, Obesity, Body Fat Distribution, and Risk of Cardiovascular Disease. , 51-74.
    CrossRef

  226. 226

    Yung Seng Lee, Ben G. Challis, Darren A. Thompson, Giles S.H. Yeo, Julia M. Keogh, Michael E. Madonna, Vicki Wraight, Matthew Sims, Vincent Vatin, David Meyre, Julian Shield, Christine Burren, Zala Ibrahim, Tim Cheetham, Peter Swift, Anthea Blackwood, Chiao-Chien Connie Hung, Nicholas J. Wareham, Philippe Froguel, Glenn L. Millhauser, Stephen O'Rahilly, I. Sadaf Farooqi. (2006) A POMC variant implicates β-melanocyte-stimulating hormone in the control of human energy balance. Cell Metabolism 3:2, 135-140
    CrossRef

  227. 227

    Rudolph L. Leibel. (2006) The molecular genetics of the melanocortin pathway and energy homeostasis. Cell Metabolism 3:2, 79-81
    CrossRef

  228. 228

    Andrea Elsner, Patrick Tarnow, Michael Schaefer, Petra Ambrugger, Heiko Krude, Annette Grüters, Heike Biebermann. (2006) MC4R oligomerizes independently of extracellular cysteine residues. Peptides 27:2, 372-379
    CrossRef

  229. 229

    M. Slawik, F. Beuschlein. (2006) Genetik und Pathophysiologie der Adipositas. Der Internist 47:2, 120-129
    CrossRef

  230. 230

    S Beckers, I Mertens, A Peeters, L Van Gaal, W Van Hul. (2006) Screening for melanocortin-4 receptor mutations in a cohort of Belgian morbidly obese adults and children. International Journal of Obesity 30:2, 221-225
    CrossRef

  231. 231

    Heike Biebermann, Tamara R. Castañeda, Frank van Landeghem, Andreas von Deimling, Frederike Escher, Georg Brabant, Johannes Hebebrand, Anke Hinney, Matthias H. Tschöp, Annette Grüters, Heiko Krude. (2006) A role for β-melanocyte-stimulating hormone in human body-weight regulation. Cell Metabolism 3:2, 141-146
    CrossRef

  232. 232

    Niamh M. Martin, Kirsty L. Smith, Stephen R. Bloom, Caroline J. Small. (2006) Interactions between the melanocortin system and the hypothalamo–pituitary–thyroid axis. Peptides 27:2, 333-339
    CrossRef

  233. 233

    Kate L.J. Ellacott, Ilia G. Halatchev, Roger D. Cone. (2006) Interactions between gut peptides and the central melanocortin system in the regulation of energy homeostasis. Peptides 27:2, 340-349
    CrossRef

  234. 234

    D. R. Powell. (2006) Obesity drugs and their targets: correlation of mouse knockout phenotypes with drug effects in vivo. Obesity Reviews 7:1, 89-108
    CrossRef

  235. 235

    Sandrine Schuhler, Francis J.P. Ebling. (2006) Role of melanocortin in the long-term regulation of energy balance: Lessons from a seasonal model. Peptides 27:2, 301-309
    CrossRef

  236. 236

    Robert G. MacKenzie. (2006) Obesity-associated mutations in the human melanocortin-4 receptor gene. Peptides 27:2, 395-403
    CrossRef

  237. 237

    Kaisa Valli-Jaakola, Jorma J. Palvimo, Marita Lipsanen-Nyman, Veikko Salomaa, Leena Peltonen, Kimmo Kontula, Camilla Schalin-J&auml;ntti. (2006) A Two-Base Deletion &ndash;439delGC in the Melanocortin-4 Receptor Promoter Associated with Early-Onset Obesity. Hormone Research 66:2, 61-69
    CrossRef

  238. 238

    L. K. George Hsu. 2006. Eating Disorders in Obesity. , 93-102.
    CrossRef

  239. 239

    Allison W Xu, Gregory S Barsh. (2006) MC4R neurons weigh in differently. Nature Neuroscience 9:1, 15-16
    CrossRef

  240. 240

    Jessica Lynn Costa, Ute Hochgeschwender, Miles Brennan. (2006) The Role of Melanocyte-Stimulating Hormone in Insulin Resistance and Type 2 Diabetes Mellitus. Treatments in Endocrinology 5:1, 7-13
    CrossRef

  241. 241

    George A. Bray. 2006. Obesity Is a Major Health Problem: Causes and Natural History. , 1-20.
    CrossRef

  242. 242

    Daniel Marks. 2005. Central Pharmacological Targets. , 491-506.
    CrossRef

  243. 243

    Joel K. Elmquist, Roberto Coppari, Nina Balthasar, Masumi Ichinose, Bradford B. Lowell. (2005) Identifying hypothalamic pathways controlling food intake, body weight, and glucose homeostasis. The Journal of Comparative Neurology 493:1, 63-71
    CrossRef

  244. 244

    Robert H. Lustig. (2005) Pediatric Endocrine Disorders of Energy Balance. Reviews in Endocrine and Metabolic Disorders 6:4, 245-260
    CrossRef

  245. 245

    (2005) Investigation of Porcine Melanocortin-4 Receptor (MC4R) Polymorphism on Economic Traits. Journal of Life Science 15:6, 968-971
    CrossRef

  246. 246

    Stergios J Moschos, Christos S Mantzoros. (2005) The emerging clinical significance of leptin in humans with absolute or relative leptin deficiency. Current Opinion in Internal Medicine 4:6, 596-601
    CrossRef

  247. 247

    Jack Yanovski, Cong Ning. 2005. Endocrine Disorders Associated with Pediatric Obesity. , 135-155.
    CrossRef

  248. 248

    Carlos Bacino, Shelley Cole, Anthony Comuzzie, Nancy Butte. 2005. Genetics of Childhood Obesity. , 79-96.
    CrossRef

  249. 249

    Samuel Dagogo-Jack. 2005. Neuroendocrine Regulation of Food Intake. , 5-25.
    CrossRef

  250. 250

    M.A. Joppa, N. Ling, C. Chen, K.R. Gogas, A.C. Foster, S. Markison. (2005) Central administration of peptide and small molecule MC4 receptor antagonists induce hyperphagia in mice and attenuate cytokine-induced anorexia. Peptides 26:11, 2294-2301
    CrossRef

  251. 251

    C. BROBERGER. (2005) Brain regulation of food intake and appetite: molecules and networks. Journal of Internal Medicine 258:4, 301-327
    CrossRef

  252. 252

    Levi Carroll, Joanne Voisey, Angela van Daal. (2005) Gene polymorphisms and their effects in the melanocortin system. Peptides 26:10, 1871-1885
    CrossRef

  253. 253

    Cedric Govaerts, Supriya Srinivasan, Astrid Shapiro, Sumei Zhang, Franck Picard, Karine Clement, Cecile Lubrano-Berthelier, Christian Vaisse. (2005) Obesity-associated mutations in the melanocortin 4 receptor provide novel insights into its function. Peptides 26:10, 1909-1919
    CrossRef

  254. 254

    I S Farooqi, S O'Rahilly. (2005) New advances in the genetics of early onset obesity. International Journal of Obesity 29:10, 1149-1152
    CrossRef

  255. 255

    Wei Fan, Adriana Voss-Andreae, Wei-Hua Cao, Shaun F. Morrison. (2005) Regulation of thermogenesis by the central melanocortin system. Peptides 26:10, 1800-1813
    CrossRef

  256. 256

    Jarrad M Scarlett, Daniel L Marks. (2005) The use of melanocortin antagonists in cachexia of chronic disease. Expert Opinion on Investigational Drugs 14:10, 1233-1240
    CrossRef

  257. 257

    C. Lubrano-Berthelier, K. Clément. (2005) Génétique de l'obésité humaine. La Revue de Médecine Interne 26:10, 802-811
    CrossRef

  258. 258

    Liang Z. Yan, David Flora, Patrick Edwards, David L. Smiley, Paul J. Emmerson, Hansen M. Hsiung, Robert Gadski, JeAnne Hertel, Mark L. Heiman, Saba Husain, Thomas P. O’Brien, Steven D. Kahl, Lianshan Zhang, Richard D. DiMarchi, John P. Mayer. (2005) Potent and selective MC-4 receptor agonists based on a novel disulfide scaffold. Bioorganic & Medicinal Chemistry Letters 15:20, 4611-4614
    CrossRef

  259. 259

    Ligang Zhou, Todd Williams, Jennifer L. Lachey, Toshiro Kishi, Michael A. Cowley, Lora K. Heisler. (2005) Serotonergic pathways converge upon central melanocortin systems to regulate energy balance. Peptides 26:10, 1728-1732
    CrossRef

  260. 260

    Lawrence Hammer, Rebecka Peebles. 2005. Childhood Obesity. .
    CrossRef

  261. 261

    I. Sadaf Farooqi. (2005) Genetic and hereditary aspects of childhood obesity. Best Practice & Research Clinical Endocrinology & Metabolism 19:3, 359-374
    CrossRef

  262. 262

    Alfonso Tortorella, Palmiero Monteleone, Emanuele Miraglia del Giudice, Grazia Cirillo, Laura Perrone, Eloisa Castaldo, Mario Maj. (2005) Melanocortin-4 receptor molecular scanning and pro-opiomelanocortin R236G variant screening in binge eating disorder. Psychiatric Genetics 15:3, 161
    CrossRef

  263. 263

    Charlotte Erlanson-Albertsson. (2005) How Palatable Food Disrupts Appetite Regulation. Basic <html_ent glyph="@amp;" ascii="&"/> Clinical Pharmacology <html_ent glyph="@amp;" ascii="&"/> Toxicology 97:2, 61-73
    CrossRef

  264. 264

    Erik Näslund, John G. Kral. (2005) Patient Selection and the Physiology of Gastrointestinal Antiobesity Operations. Surgical Clinics of North America 85:4, 725-740
    CrossRef

  265. 265

    Ya-Xiong Tao. (2005) Molecular mechanisms of the neural melanocortin receptor dysfunction in severe early onset obesity. Molecular and Cellular Endocrinology 239:1-2, 1-14
    CrossRef

  266. 266

    M S Faith. (2005) Development and modification of child food preferences and eating patterns: behavior genetics strategies. International Journal of Obesity 29:6, 549-556
    CrossRef

  267. 267

    Anthony P Coll, Benjamin G Challis, Giles S. H Yeo, I Sadaf Farooqi, Stephen O??Rahilly. (2005) Melanocortin receptors and energy homeostasis. Current Opinion in Endocrinology & Diabetes 12:3, 205-210
    CrossRef

  268. 268

    Roger D Cone. (2005) Anatomy and regulation of the central melanocortin system. Nature Neuroscience 8:5, 571-578
    CrossRef

  269. 269

    Karine Clément. (2005) Genetics of human obesity. Proceedings of the Nutrition Society 64:02, 133-142
    CrossRef

  270. 270

    George A. Bray, Catherine M. Champagne. (2005) Beyond Energy Balance: There Is More to Obesity than Kilocalories. Journal of the American Dietetic Association 105:5, 17-23
    CrossRef

  271. 271

    R J F Loos, T Rankinen, A Tremblay, L Pérusse, Y Chagnon, C Bouchard. (2005) Melanocortin-4 receptor gene and physical activity in the Québec Family Study. International Journal of Obesity 29:4, 420-428
    CrossRef

  272. 272

    Allison B Goldfine. (2005) Beyond the scale: understanding mechanisms of weight gain and obesity in diabetes. Current Opinion in Endocrinology & Diabetes 12:2, 143-145
    CrossRef

  273. 273

    Tung M Fong. (2005) Advances in anti-obesity therapeutics. Expert Opinion on Investigational Drugs 14:3, 243-250
    CrossRef

  274. 274

    Christopher G. Bell, Andrew J. Walley, Philippe Froguel. (2005) The genetics of human obesity. Nature Reviews Genetics 6:3, 221-234
    CrossRef

  275. 275

    Adrian J Park, Stephen R Bloom. (2005) Neuroendocrine control of food intake. Current Opinion in Gastroenterology 21:2, 228-233
    CrossRef

  276. 276

    I. Sadaf Farooqi, Stephen O'Rahilly. (2005) Monogenic Obesity in Humans. Annual Review of Medicine 56:1, 443-458
    CrossRef

  277. 277

    John G. Kral. (2005) The pathogenesis of obesity: Stress and the brain-gut axis. Surgery for Obesity and Related Diseases 1:1, 25-34
    CrossRef

  278. 278

    Gilbert C. Liu, Tamara S. Hannon. (2005) Reasons for the Prevalence of Childhood Obesity. The Endocrinologist 15:1, 49-55
    CrossRef

  279. 279

    S. I. Barr. 2005. Calcium and obesity. , 431-447.
    CrossRef

  280. 280

    C. Verdich, K. Clement, T. Sorenson. 2005. Nutrient-gene interactions contributing to the development of obesity. , 17-57.
    CrossRef

  281. 281

    K Steinbeck, A Pietrobelli. (2005) Pediatric obesity highlight: looking into the future. International Journal of Obesity 29:1, i-ii
    CrossRef

  282. 282

    C.H. Vaughan, Marcus C. Moore, C. Haskell-Luevano, N.E. Rowland. (2005) Meal patterns and foraging in melanocortin receptor knockout mice. Physiology & Behavior 84:1, 129-133
    CrossRef

  283. 283

    B.G. Irani, Z. Xiang, M.C. Moore, R.J. Mandel, C. Haskell-Luevano. (2005) Voluntary exercise delays monogenetic obesity and overcomes reproductive dysfunction of the melanocortin-4 receptor knockout mouse. Biochemical and Biophysical Research Communications 326:3, 638-644
    CrossRef

  284. 284

    Miles D. Thompson, W. McIntyre Burnham, David E. C. Cole. (2005) The G protein-coupled receptors: Pharmacogenetics and Disease. Critical Reviews in Clinical Laboratory Sciences 42:4, 311-389
    CrossRef

  285. 285

    , FINN EDLER EYBEN, JENS PETER KROUSTRUP, JENS FROMHOLT LARSEN, JULIO CELIS. (2004) Comparison of Gene Expression in Intra-Abdominal and Subcutaneous Fat: A Study of Men with Morbid Obesity and Nonobese Men Using Microarray and Proteomics. Annals of the New York Academy of Sciences 1030:1, 508-536
    CrossRef

  286. 286

    Kate S Steinbeck. (2004) The Future of Obesity Management. Clinical Obstetrics and Gynecology 47:4, 942-956
    CrossRef

  287. 287

    Maria Belen Roldan Martin, Carlie White, Candice Kammerer, Selma Feldman Witchel. (2004) Mutational analysis of the melanocortin-4 receptor (MC4R) gene in children with premature pubarche and adolescent girls with hyperandrogenism. Fertility and Sterility 82:5, 1460-1462
    CrossRef

  288. 288

    Giles S H Yeo, Chiao-Chien Connie Hung, Justin Rochford, Julia Keogh, Juliette Gray, Shoba Sivaramakrishnan, Stephen O'Rahilly, I Sadaf Farooqi. (2004) A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nature Neuroscience 7:11, 1187-1189
    CrossRef

  289. 289

    Gary J. Schwartz. (2004) Biology of Eating Behavior in Obesity. Obesity 12, 102S-106S
    CrossRef

  290. 290

    Jesse Roth, Xiaoling Qiang, Sharon Lee Marbán, Henry Redelt, Barbara C. Lowell. (2004) The Obesity Pandemic: Where Have We Been and Where Are We Going?. Obesity 12, 88S-101S
    CrossRef

  291. 291

    Supriya Srinivasan, Cecile Lubrano-Berthelier, Cedric Govaerts, Franck Picard, Pamela Santiago, Bruce R. Conklin, Christian Vaisse. (2004) Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans. Journal of Clinical Investigation 114:8, 1158-1164
    CrossRef

  292. 292

    Xueying Lin, Akiko Taguchi, Sunmin Park, Jake A. Kushner, Fan Li, Yedan Li, Morris F. White. (2004) Dysregulation of insulin receptor substrate 2 in β cells and brain causes obesity and diabetes. Journal of Clinical Investigation 114:7, 908-916
    CrossRef

  293. 293

    J. Salvador Rodríguez, F. Payeras Mas, C. Silva Froján, G. Frühbeck Martínez. (2004) Obesidad. Concepto. Clasificación. Implicaciones fisiopatológicas. Complicaciones asociadas. Valoración clínica. Medicine - Programa de Formación Médica Continuada Acreditado 9:19, 1167-1175
    CrossRef

  294. 294

    R. D. Houston, N. D. Cameron, K. A. Rance. (2004) A melanocortin-4 receptor ( MC4R ) polymorphism is associated with performance traits in divergently selected large white pig populations. Animal Genetics 35:5, 386-390
    CrossRef

  295. 295

    Gary J Schwartz, Anthony V Azzara. (2004) Sensory neurobiological analysis of neuropeptide modulation of meal size. Physiology & Behavior 82:1, 81-87
    CrossRef

  296. 296

    J. Hebebrand, A.-K. Wermter, A. Hinney. (2004) Adipositas. Monatsschrift Kinderheilkunde 152:8, 870-876
    CrossRef

  297. 297

    Ryouichi Banno, Hiroshi Arima, Ikuko Sato, Masayuki Hayashi, Motomitsu Goto, Yoshihisa Sugimura, Takashi Murase, Yutaka Oiso. (2004) The melanocortin agonist melanotan II increases insulin sensitivity in OLETF rats. Peptides 25:8, 1279-1286
    CrossRef

  298. 298

    Aurawan Vongs, Nicole M Lynn, Charles I Rosenblum. (2004) Activation of MAP kinase by MC4-R through PI3 kinase. Regulatory Peptides 120:1-3, 113-118
    CrossRef

  299. 299

    Arne Astrup, James O Hill, Stephan Rossner. (2004) The cause of obesity: are we barking up the wrong tree?. Obesity Reviews 5:3, 125-127
    CrossRef

  300. 300

    Jodi F Evans, Qing-Tian Niu, J.Atilio Canas, Chwan-L Shen, John F Aloia, James K Yeh. (2004) ACTH enhances chondrogenesis in multipotential progenitor cells and matrix production in chondrocytes. Bone 35:1, 96-107
    CrossRef

  301. 301

    L Arthur Campfield, Françoise Smith. 2004. Leptin and Other Appetite Suppressants. , 321-344.
    CrossRef

  302. 302

    Rexford Ahima, Suzette Osei. 2004. Central Targets for Antiobesity Drugs. , 299-321.
    CrossRef

  303. 303

    Philippe Froguel, Philippe Boutin. 2004. Genetics of Obesity. , 53-67.
    CrossRef

  304. 304

    J.Larry Jameson. (2004) Molecular mechanisms of end-organ resistance. Growth Hormone & IGF Research 14, 45-50
    CrossRef

  305. 305

    William T Gibson, Barbara J Ebersole, Sumit Bhattacharyya, Peter Clayton, I Sadaf Farooqi, Stuart C Sealfon, Stephen O'Rahilly. (2004) Mutational analysis of the serotonin receptor 5HT2c in severe early-onset human obesity. Canadian Journal of Physiology and Pharmacology 82:6, 426-429
    CrossRef

  306. 306

    Jay Shendure, Robi D. Mitra, Chris Varma, George M. Church. (2004) Advanced sequencing technologies: methods and goals. Nature Reviews Genetics 5:5, 335-344
    CrossRef

  307. 307

    Giuseppe Matarese, Antonio La Cava. (2004) The intricate interface between immune system and metabolism. Trends in Immunology 25:4, 193-200
    CrossRef

  308. 308

    F GELLER, K REICHWALD, A DEMPFLE, T ILLIG, C VOLLMERT, S HERPERTZ, W SIFFERT, M PLATZER, C HESS, T GUDERMANN. (2004) Melanocortin-4 Receptor Gene Variant I103 Is Negatively Associated with Obesity. The American Journal of Human Genetics 74:3, 572-581
    CrossRef

  309. 309

    Allen M. Spiegel, Lee S. Weinstein. (2004) Inherited Diseases Involving G Proteins and G Protein–Coupled Receptors *. Annual Review of Medicine 55:1, 27-39
    CrossRef

  310. 310

    Jason M Langheier, Ralph Snyderman. (2004) Prospective medicine: the role for genomics in personalized health planning. Pharmacogenomics 5:1, 1-8
    CrossRef

  311. 311

    Myles S Faith, Kathleen L Keller. (2004) Genetic architecture of ingestive behavior in humans. Nutrition 20:1, 127-133
    CrossRef

  312. 312

    Paska A Permana, Angelo Del Parigi, P.Antonio Tataranni. (2004) Microarray gene expression profiling in obesity and insulin resistance. Nutrition 20:1, 134-138
    CrossRef

  313. 313

    Coleen M Damcott, Paul Sack, Alan R Shuldiner. (2003) The genetics of obesity. Endocrinology & Metabolism Clinics of North America 32:4, 761-786
    CrossRef

  314. 314

    A. L. Diament, J. S. Fisler, C. H. Warden. (2003) Studies of natural allele effects in mice can be used to identify genes causing common human obesity. Obesity Reviews 4:4, 249-255
    CrossRef

  315. 315

    R. J. F. Loos, C. Bouchard. (2003) Obesity - is it a genetic disorder?. Journal of Internal Medicine 254:5, 401-425
    CrossRef

  316. 316

    Hans-Rudolf Berthoud. (2003) Neural systems controlling food intake and energy balance in the modern world. Current Opinion in Clinical Nutrition and Metabolic Care 6:6, 615-620
    CrossRef

  317. 317

    Matthias Barton, Jörg Furrer. (2003) Cardiovascular consequences of the obesity pandemic: need for action. Expert Opinion on Investigational Drugs 12:11, 1757-1759
    CrossRef

  318. 318

    Karoline Schousboe, Gonneke Willemsen, Kirsten O Kyvik, Jakob Mortensen, Dorret I Boomsma, Belinda K Cornes, Chayna J Davis, Corrado Fagnani, Jacob Hjelmborg, Jaakko Kaprio, Marlies de Lange, Michelle Luciano, Nicholas G Martin, Nancy Pedersen, Kirsi H Pietiläinen, Aila Rissanen, Suoma Saarni, Thorkild I.A Sørensen, G. Caroline M van Baal, Jennifer R Harris. (2003) Sex Differences in Heritability of BMI: A Comparative Study of Results from Twin Studies in Eight Countries. Twin Research and Human Genetics 6:5, 409-421
    CrossRef

  319. 319

    Guttmacher, Alan E., Collins, Francis S., . (2003) Welcome to the Genomic Era. New England Journal of Medicine 349:10, 996-998
    Full Text

  320. 320

    (2003) Binge Eating as a Phenotype of Melanocortin 4 Receptor Gene Mutations. New England Journal of Medicine 349:6, 606-609
    Full Text

  321. 321

    List, James F., Habener, Joel F., . (2003) Defective Melanocortin 4 Receptors in Hyperphagia and Morbid Obesity. New England Journal of Medicine 348:12, 1160-1163
    Full Text

  322. 322

    Vivien K L Toh, John A H Wass. (2001) What's new in... Endocrinology. Medicine 29:11, i-vi
    CrossRef